A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection

SARS-CoV-2, a novel Corona virus strain, was first detected in Wuhan, China, in December 2019. As of December 16, 2021, almost 4,822,472 people had died and over 236,132,082 were infected with this lethal viral infection. It is believed that the human immune system is thought to play a critical role in the initial phase of infection when the viruses invade the host cells. Although some effective vaccines have already been on the market, researchers and many bio-pharmaceuticals are still working hard to develop a fully functional vaccine or more effective therapeutic agent against the COVID-19. Other efforts, in addition to functional vaccines, can help strengthen the immune system to defeat the corona virus infection. Herein, we have reviewed some of those proven measures, following which a more efficient immune system can be better prepared to fight viral infection. Among these, dietary supplements like- fresh vegetables and fruits offer a plentiful of vitamins and antioxidants, enabling to build of a healthy immune system. While the pharmacologically active components of medicinal plants directly aid in fighting against viral infection, supplementary supplements combined with a healthy diet will assist to regulate the immune system and will prevent viral infection. In addition, some personal habits, like- regular physical exercise, intermittent fasting, and adequate sleep, had also been proven to aid the immune system in becoming an efficient one. Maintaining each of these will strengthen the immune system, allowing innate immunity to become a more defensive and active antagonistic mechanism against corona-virus infection. However, because dietary treatments take longer to produce beneficial effects in adaptive maturation, personalized nutrition cannot be expected to have an immediate impact on the global outbreak.

Introduction

Human coronavirus was first discovered in the 1960s by Tyrrell and Bynoe (1, 2), who isolated it from a young boy who was affected with the common cold and named it B814. In November 2002, a new disease appeared in the Guangdong Province of China resembling acute respiratory illness linked to pneumonia, but the actual reason was unknown (3). Later, World Health Organization (WHO) and Centres for Disease Control and Prevention (CDC) declared that a member of the Coronavirus family had never been found before in human and was the causative representative of severe acute respiratory syndrome (SARS) in April 2003. It affected 8000 people in 30 countries across five continents (4, 5). In 2004, NL63 (HCoV-NL63) Corona-virus was found in the Netherlands from a seven-month-old child with bronchiolitis and conjunctivitis (6). In 2012, Zaki et al. reported an unknown strain of Coronavirus in a patient with seven days of fever, cough, and respiratory problems in Saudi Arabia (7). Recently, a cluster of pneumonia events of unfamiliar causes was found in Wuhan in December 2019 (8, 9). SARS-CoV-2 has a mode of proliferation that allows it to spread quickly across the globe, causing mortality to a significant proportion of individuals worldwide and became a major public health concern. Although 2020 was a difficult year, 2021 appears to be even more challenging due to various SARS-CoV-2 variants. The emergence of the novel 501Y.V1 (B.1.1.7) variants of SARS-CoV-2 in the UK and 501Y.V2 (B.1.351) in South Africa was attributed to an unforeseen increase in the confirmed cases of COVID-19 in December 2020 (10). In the receptor-binding portion of the spike protein, the two variants had mutations (N501Y) that contributed 40 to 70% increased transmission (11). SARS-CoV-2 first enters into the target cell, human upper respiratory tract, by interacting with angiotensin-converting enzyme 2 (ACE2) found in epithelial cells of the respiratory tract, gastrointestinal (GI) tract and excretory system and usurp the host cellular machinery to propagate and then internalized by receptor-mediated endocytosis forming early endosome containing virus (12, 13). Following that, the virus enters into the pulmonary alveolar epithelial cells, and at acidic pH, the lipid envelope of virus fuses with the endosomal membrane (late endosome) and viral nucleic acids are released inside the host cells where viruses form negative-strand RNA (-sRNA) using the pre-existing single strand positive RNA (+ssRNA) as template and RNA polymerase enzyme (14, 15). SARS-CoV-2 composes several proteins translated into the functional RNA Polymerase protein via the host ribosome machinery as nucleocapsid (N), spike (S), membrane (M), and envelope (E). N protein translation occurs in the cytoplasm, whereas S, M, and E protein occur in the rough endoplasmic reticulum (RER) due to post-translational modification. The structural proteins S, M, and E combine with the viral nucleocapsid (N) (16, 17).

Various targets are presented, such as- a) The RNA-dependent RNA polymerase (RdRp) enzyme in COVID-19 is made up of the non-structural proteins nsp12, nsp8, and nsp7 (18) and acts as an effective target for preventing viral RNA production (19). b) The spike protein interacts with the ACE2 receptor to initiate the initial connection between the SARS-CoV-2 and the host (20). Other structural proteins, such as membrane M protein and envelope E protein, are important in viral entry into the host cell (21). c) Another potential target is the major protease (M^pro), also known as viral 3-chymotrypsin-like cysteine protease (3CL^pro), which is involved in the processing of newly translated proteins for viral replication (22, 23).

The clinical symptoms of this infection were similar to flu, a few patients developed a critical condition that included fever (87.9%), dry cough (67.71%), fatigue (38.5%), and even death (3.4%) (24–26). Additionally, myalgia or exhaustion (14.8%), sputum (33.4%), headaches (11.4%), nasal congestion (4.8%), and diarrhoea (3.7%) are typical indications and signs (24). COVID-19 Symptoms appear between 2 and14 days after infection, however, the patients might also show no symptoms; asymptomatic transmission (27). Several vaccines (e.g. Oxford-AstraZeneca, Pfizer-BioNTech, Sinopharm, Moderna, and Sputnik Janssen) have been used for COVID-19 but they are not available for all people (28–30). Moreover, several studies have already suggested the vaccine escape mutants (31). The early approval of SARS-CoV-2 vaccines has several limitations (31). It was the first mRNA/DNA vaccine without long term safety data. All of the vaccines were approved without having any prior knowledge of late side effects and duration of protection. Also, there was no authorized vaccine for human corona viruses and vaccines against common cold viruses are usually short-lived and less effective. Moreover, SARS-CoV-2 is RNA virus, so its mutation rate is so high (32). That’s why, there is no vaccine which defeated the COVID-19 disease fully (33). Because the established vaccines are made for particular strain, so the vaccine’s efficiency is low in other strains. We also don’t have the clear concept of those vaccine doses that how many doses we take or not, how many days gap between the doses and is there necessary for booster dose or not for every vaccine (34). Scientists are worked on it and try to establish a new vaccine which prevents all types of strain in COVID-19 disease (35).

Using mask while roaming outside, maintaining social distance, using sanitization, taking healthy foods, maintaining proper isolation system and always trying washing hands in every 5 minutes and avoiding touching hand or mouth (36–39). That’s the way of improving the life style that ensures strengthening the immune system even after recovery of COVID-19 infection. SARS-CoV-2 is a positive sense RNA virus; therefore, the mutation of its genome is comparatively high. That’s why no specific drug or vaccine could prevent this virus. The strengthen immunity is the only way to combat against SARS-CoV-2 and defeat COVID-19. Everybody should follow the COVID-19 protocol properly, taking healthy foods and doing physical exercise daily for boosting up the immunity to prevent and defeat this disease. A low-carbohydrate diet will help reduce the progression of diabetes, while a protein-rich diet helps keep the body in good health. It is recommended that Beta carotene, ascorbic acid, and other vital vitamins be consumed on a daily basis (40). Certain foods, such as mushrooms, tomato, and bell pepper, as well as green vegetables like broccoli and spinach, can help the body establish resistance against COVID-19 infections. The best strategy to help develop immunity is to get 7-8 hours of sleep (41). Sleep deprivation prevents the body from resting, impairing other physical activities that have a direct impact on the immune system (42).

Thus, when an individual is infected, the immune system becomes indispensable. Adaptive immunity is the system that human bodies designed to battle bacteria, viruses, and other substances that are previously unknown to them. Therefore, the immune system as a whole must be capable of recognizing and combating any infection caused by foreign substances (43). The theory demonstrates immunity, especially in young ages of individuals recovering from viral attacks. Older people and children have relatively low immunity and are thus more likely to become heavily infected with these infections (30). As the symptoms of COVID-19 are more intense in people who have pre-existing diseases and are immunocompromised, possible protection strategies include controlling pre-existing diseases and strengthening the immune system (44). As a vital regulator of the immune system, small deficiencies of some micronutrients could hamper the immune response (45). The immune system needs nutrients, including microelements and vitamins, herbal therapies, and probiotics to fight against COVID-19 (46). Additionally, dietary supplements containing minerals have a positive influence on immunological responses to viral infections.This review aims to compile all available information about strengthening the immune system to combat coronavirus infection and spread the message that prevention is far superior to cure. A schematic overview of this review has been depicted in Figure 1.

FIGURE 1

Figure 1 Overview of measures essential to boost immunity against COVID-19. One can boost immunity by using proper guidelines of a healthy lifestyle (Adequate food, physical exercise, sleeping).

Role of Immune System Against COVID-19 Infection

The immune system is the greatest defence line against any infection; it supports to human natural capacity to protect against pathogens (e.g., viruses, bacteria, fungi, protozoans, and worms) and resists infections. COVID-19 infections are undiagnosed as long as the immune system is functioning properly. Although innate immunity (quick response), adaptive immunity (delayed response), and passive immunity are the three types of defense mechanisms that work against infections, this review focuses on factors that improve innate immunity, as well as the importance of developing an effective vaccine and antiviral drugs.

The key role of the immune system against COVID-19 is precise to certain structural features of SARS-CoV-2. Particular proteins and specific sequences of the viral genome known as pathogen-associated molecular patterns (PAMPs) induce the immune response against the viruses (47, 48). Viral double-stranded RNA, nucleocapsid, membrane protein, and surface glycoprotein are some of the significant viral PAMPs. These PAMPs are accepted by specific intracellular pattern recognition receptors (PRRs) present in the human body. Upon recognizing of PAMPs, PRRs trigger the expression of certain interferon’s, cytokines, and antiviral interferon-producing genes, like- IFN3, IFN7, and the plethora of interleukins (IL) (49). Together, they inhibit viral replication and prevent viral spread. Contrarily, adaptive immunity works precisely and exhibits a more tailored immune response to the virus infecting the host cells. CD8+ cells and dendritic cells play the central role in this process; as they entrap, process, and present the viral antigens to the CD8+ cytotoxic T lymphocytes and natural killer (NK) cells (47, 50) followed by inducing an inflammatory response leading to the movement of monocytes and neutrophils to the virus-infected cells. These cells together with other interleukins- IL-1,6,8,21 and TNF-β kill virus-infected cells and inhibit viral replication (47, 51).

All the vital immune cells mentioned above produce cytokines and have an efficient immune response against COVID-19 that is highly dependent on the nutritional status of the host and the presence of certain vitamins and metabolites. Moreover, some external factors like- physical exercise, intermittent fasting, and adequate sleeping have also been reported to facilitate and enhance immune response (42, 52–54). Hence, the role of the immune system against COVID-19 is very vital, and it can only be replenished by maintaining some simple lifestyle practice until fully-functional vaccines and specific anti-viral drugs have been developed and reached to all the people in the world.

Vegetables and Fruits in Daily Diet to Protect COVID-19

Vegetables and Fruits contain a plethora of vitamins, minerals, and other micro and macronutrients that help us to build up stronger resistance against viral and other infections. As there is no effective treatment for coronavirus infection, the best option is to build up immunity to prevent COVID-19 infection. For that, fruits containing vitamins and other macromolecules that can elicit potential resistance against viral infection or other respiratory tract infections should be included in the daily diet. Table 1 enlists recommended requirements of some major nutrients that should be included in the daily diet.

TABLE 1

Table 1 Recommended minimum dietary intake of essential nutrients for adults.

Carrots, kale, mangoes, spinach, apricots, broccoli, sweet potatoes, squash, and cantaloupe contain a good amount of vitamin A that can be added to the daily diet. The vegetables mentioned above and other colorful vegetables contain beta carotene, which when consumed, gets converted into vitamin A considered crucial for a robust immune system. Many studies support that vitamin A has both promoting and regulatory roles in both innate and adaptive immunity (58). Therefore, it can enhance the immune system and provide improved defense against coronavirus infection.

It is known that Acute Respiratory Distress Syndrome (ARDS) is a crucial factor of fatality in SARS-CoV-2, rapid release of high amounts of free radicals and increased oxidative stress leads to cellular catastrophe, internal organ failure, and eventually death. Lentils, beans, tofu, chickpeas, fortified cereals, seeds, nuts, wheat germ, etc., should also be considered as an important food component. These plant-derived products are rich in zinc, which enhances immunity toward viral infection by altering the resistance of the host (59, 60).

Medicinal Plants and Herbs to Reinforce Protection Against Viral Infection

Various plants, herbs, or their specific parts are traditionally used worldwide due to their antimicrobial activity. Many antimicrobial agents extracted from different plants can promote immune cell proliferation and enhance the immune response by providing an excellent antiviral activity. Anti-inflammatory medicinal plants may have a pleiotropic role in COVID-19 treatment, as elevated levels of inflammatory markers such as interleukin (IL)-6, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) have been linked to severe disease and poor outcomes in COVID-19 patients, most likely due to cytokine storm (61).

Garlic has antiviral activity against herpes simplex virus 1 (HSV-1), influenza A and B, viral pneumonia, human immunodeficiency viruses (HIV), and common cold-causing rhinoviruses (62). Recent research also shows that garlic can enhance immunity by activating protective immune cells against viral infection (63). Garlic appears to boost immune system activity by modulating cytokine production, phagocytosis, macrophage activation, and immunoglobulin synthesis by activating NK cells, lymphocytes, eosinophils, and dendritic cells (DC) (64).

Ginger due to the high concentration of potent plant compounds, has been a potential antiviral agent for centuries. In vitro research has shown that the extract of ginger has some antiviral activities on avian as well as respiratory syncytial viruses (RSVs) (65, 66). In addition, gingerols and zingerones impede viral replication and counteract the viruses from penetrating host cells (67). The ginger extract inhibited TNF-α, IL-12, IL-1β (pro-inflammatory cytokines) production in LPS stimulated macrophages. Ginger extract down-regulated the expression of B7.1, and MHC class II molecules. Researchers studied the effect of ginger extract on the expression of proinflammatory cytokines and chemokines in murine peritoneal macrophages and also observed a reduction in T cell proliferation at a significant level in response to all stimulation (68).

Oregano is well known for its medicinal properties, a common herb in the mint family. The prime compound found in it is carvacrol, which provides antiviral properties. Oregano oil and carvacrol exhibited antiviral activity against herpes simplex virus (HSV), rotavirus, and, importantly, respiratory syncytial viruses (RSVs), causing respiratory infection (69, 70).

Tulsi is the holy variety of basil with the property to increase immunity to help us against viral infection. A study showed that extract supplementation of holy basil notably raised T cells levels and NK cells (71).

Basil includes compounds such as apigenin and ursolic acid that have potent antiviral activity in opposition to many viral infections in a particularly sweet variety of basil (72). It has also been found to boost up the immunity that may assist in striving for other diseases.

Sage a member of the mint tribe, is a scented herb. It has been utilized from age-long to medicate viral type infections in conventional medicine (73). Safficinolide and sage, contained in the plant leaves and stems, are the compounds responsible for the antiviral properties (74). One study by Geuenich et al. reported significant inhibition of HIV entry into the host cell following the application of sage extract, which is also a RNA virus-like SARS-CoV-2 (75). Further study may establish potential preventive measures against COVID-19.

Fennel is a licorice plant with a potent antiviral effect on herpes viruses and parainfluenza type-3, which cause cattle breathing infections (76). The key element of fennel essential oil, trans-anethole, has demonstrated promising antiviral effects in opposition to the herpes virus (77). It can also improve the immune system and relieve inflammation, according to animal-based studies (78).

Lemonbalm is commonly used in tea and seasoning as a lemony herb, but it has some medicinal significance as well. Lemon balm extract is a potent essential oil that has antiviral activity, and a study has already shown it has significant antiviral effects against HIV-1 (75), avian influenza (79), herpesviruses (80, 81) as well as enterovirus (82).

Licorice is one of those herbs that has been used in traditional Chinese medicine for years (83) Some of the active substances in licorice are glycyrrhizin, liquiritigenin, and glabridin, which exhibit significant antiviral properties (84). The root extract of licorice has been found effective against Influenzae (85), HIV, RSV (86), HBV (83), herpes virus (87), and, most importantly, SARS-CoV-2 (88).

Dandelion although considered as a weed has been studied for possible antiviral effects. Research has shown that replication of hepatitis B (89), HIV (90), and influenza (91) can be blocked by dandelion.

Moringa leaves and seeds are enriched in vitamin C, vitamin A, calcium, and potassium content. The traditional, industrial, nutritional, and medicinal values used in folk medicine are diversified in Moringa oleifera for numerous health reasons, especially for the symptoms (e.g., fever, muscle pain, or asthma) of COVID-19 patients (92). Moringa peregrina has several pharmacological properties, including anti-microbial, anti-diabetic, antioxidant, anti-inflammatory, anti-spasmodic, anticancer, reduction of lipid activity, and cognitive problems (95). Black cumin, a component of this plant, is well-known in obstructive respiratory conditions for its robust immune regulation, anti-inflammation, and antioxidant advantages that have been used for decades for medicinal purposes (93, 94). Thymoquinone, Nigellidine, and α-hederine from N. sativa can impact the immune responses against COVID-19 on molecular grounds (95, 96).

Plants including Glycyrrhiza glabra, Allium sativum, and Clerodendruminerme Gaertn have been proven to impede SARS-CoV virus replication, making them potential SARS-CoV-2 fighters (97). In India, extracts of sunthi (Zingiber officinale Roscoe.), lavanga (Syzygiumaromaticum), and maricha (Piper nigrum) are used to prevent and treat COVID-19 because they stimulate humoral and cell-mediated responses and reduce respiratory hyperresponsiveness and nasal congestion (98). Andrographis paniculata, a tropical species found in South Asia, inhibited elevated NOD-like receptor protein 3 (NLRP3), caspase-1, and IL-1 molecules, all of which are associated in the pathogenesis of SARS-COV and, most certainly, SARS-CoV-2 (97). Decoction of Tinospora cordifolia, Andrograhispaniculata, Cydonia oblonga, Zizyphus jujube, Cordia myxa and Arsenicum album 30 have been suggested to prevent respiratory infections (97, 98). In China, Lianhuaqingwen, a Traditional Chinese Medicine (TCM) formula comprised of 13 herbs (Supplementary Table 1), is being used as a possible therapeutic candidate for the management and cure of COVID-19 because it inhibited SARS-CoV-2 replication, lowered pro-inflammatory cytokine secretion, and altered the morphology of SARS-CoV-2 cells (99, 100). Furthermore, a study report demonstrated the bioactive efficacy of extracts Sanctellaria baicalensis containing baicalin, which is considered one of the most important TCM herbal constituents, as well as hesperetin, an active component found in tangerine peel, in alleviating COVID-19 symptoms (98, 101). A range of investigations are being carried out in order to develop a formulation against coronavirus using medicinal plants and herbs (Table 2). The biomolecules are the basis for establishing successful treatment against several protein targets of SARS-CoV-2 including Nsp1, Nsp3 (Nsp3b, Nsp3c, PL^pro and Nsp3e), Nsp7-Nsp8, Nsp9-Nsp10, Nsp14-Nsp16 complexes, 3CL^pro, E protein, ORF7a, Spike (S) glycoprotein, C-terminal RNA binding domain (CRBD), N- terminal RNA binding domain (NRBD), helicase and RdRp (115). Despite the fact that various medicinal plants have been identified as efficient antiviral treatments for COVID-19, additional research is required.

TABLE 2

Table 2 Applications of medicinal plants and herbs as possible therapeutics against COVID-19 infection.

Vitamins and Food Supplements to Enhance Immunity Against Viral Infection

Vitamins significantly boost immunity by supporting different biochemical reactions important for immune response and helping fight infections. Hence, vitamins are considered to be a potential weapon to prevent coronavirus infection (117). A comprehensive table of vitamin requirements for different age groups is given in Table 3.

TABLE 3

Table 3 Daily Requirement of Vitamins for Different Aged People (118).

Vitamin A are available as its active forms retinal, retinol, and, especially, retinoic acid (RA), which mediate the transcription of hundreds of genes implicated in several biological pathways (119). Vitamin A enhanced the antioxygenic capacity of the tissues in extended amounts and it is proposed that retinol could even be regarded as an antioxidant similar to the tocopherol in human nutrition as well as play a key role in the modulation and regulation of the immune system, including innate and adaptive responses, which may enact a crucial element in the fight against pathogens (119, 120). A prospective, multicenter observational cross-sectional study showed that vitamin A plasma levels in COVID-19 patients are reduced during acute inflammation and that severely reduced plasma levels of vitamin A are significantly associated with ARDS and mortality (120). Systematic reviews and meta-analyses have reported that retinoid administration improves symptoms related to acute pneumonia, and also reduces incidence, morbidity, and mortality of measles (119). Therefore, and even though there is still no clinical evidence regarding vitamin A and COVID-19, in the light of its roles in lung function and immunity, the vitamin is currently being investigated for the treatment of SARS-CoV-2 infection alongside with other antioxidants.

Vitamin B performs a significant role in the body’s immune system. Since the lack of vitamin B will impair the immune reaction of the host, patients diagnosed with the virus should be supplemented to strengthen their immune system (87). Some of the food products rich in folate (natural form vitamin B) - are the kernel, peanuts, fruits, and green vegetables (121).

Vitamin C is a water-soluble vitamin that acts as an effective reducing agent, as well as having antioxidant, immunomodulating, antiviral and antithrombotic activities. It plays an important role in the immune system by supporting the epithelial barrier against pathogen invasion and the cellular processes of the innate and adaptive immune systems (117, 119, 122, 123). Figure 2 summarizes the role of vitamin C in phagocytic cells that participate in pathogen defense and the amount of vitamin C found in certain common fruits (119, 127). Vitamin C may boost the immune response to viral infections by stimulating T-lymphocytes and NK-lymphocytes proliferation and activation, as well as interferon production (124). It also increases the quantity of antibodies in the blood and aids lymphocytes differentiation, both of which are necessary for resistance to viral infection (110). Vitamin C strengthens the immune system (Supplementary Table 2) and protects against coronavirus infection (128). For example, it enhanced the resistance of chick embryo tracheal organ cultures to infection and protected broiler chicks against an avian coronavirus as well as can ameliorate flu-like symptoms (sneezing, a running nose, and swollen sinuses) as a mild antihistaminic agent (124, 129, 130). Furthermore, vitamin C therapy reduced the effects of sepsis on pulmonary dysfunction in septic mice with ARDS by down regulating proinflammatory genes and improving epithelial membrane permeability (124, 125). A recent report revealed that, vitamin C increases the antiviral activity of lung epithelial cells and protects lung fibrosis and damage in both in vivo and in vitro models (131). Previous placebo-control trials found that high-dose vitamin C (2-16 g/day) was successful in reducing the mortality of patients with sepsis, severe influenza, and acute lung damage as well as reducing the length of stay in the intensive care unit (ICU) and the duration of mechanical ventilation (124, 125, 131). Additionally, vitamin C may modulate the cytokine storm, which is characterized by elevated levels of the proinflammatory cytokine interleukin (IL)-6, increasing the likelihood of respiratory failure necessitating mechanical ventilation in COVID-19 patients (125). As severe COVID-19 infection can lead to sepsis and ARDS, numerous studies have attempted to alleviate these symptoms with high doses of vitamin C (131). Several clinical trials have been ongoing since initial trials in China and the United States reported the beneficial effects of high-dose intravenous (IV) vitamin C, but due to the excellent safety profile of vitamin C and the need for ICU treatment for a huge percentage of COVID-19 cases, clinical application of vitamin C has been proposed by many authors, even before the outcomes of large clinical trials are available (119, 124, 131).

FIGURE 2

Figure 2 (A) Role of vitamin C in phagocytosis (Vitamin C promotes neutrophil movement in response to chemoattractants and microbes engulfment, as well as formation of reactive oxygen species and microbial death. It also stimulates caspase-dependent apoptosis, boosting macrophage uptake and clearance, and suppresses necrosis, including NETosis, promoting inflammatory resolution and reducing tissue damage). (B) Amount of vitamin C in selected fruits (per 100 g) (124–126).

Vitamin D is a type of fat-soluble secosteroid responsible for enhancing the intestinal synthesis of calcium, magnesium, phosphate, and many other biological activities (Supplementary Table 2) (132). In humans, vitamin D2 (known as ergocalciferol) and vitamin D3 (cholecalciferol) are the most common compounds from this class of vitamin (133). It usually acts to stimulate the endogenous and dampen the adaptive immune systems (Figure 3) (134). The risk of acute respiratory tract infections and asthma exacerbation can be marginally mitigated through vitamin D supplementation (135). It can be synthesized with the support of sunlight in the bodies (136). The vitamin D receptor (VDR) is also located in lung epithelial cells, where it regulates the synthesis of defensins and catelicidins, peptides that have antiviral effect either directly or through immunological regulation (125). The decreased vitamin D level in the calves was documented to raise susceptibility to bovine coronavirus infection (132, 137). It has been hypothesized that the reduced antiviral immune response in COVID-19 patients during vitamin D deficiency could be attributable to a decrease in LL37 levels, an antimicrobial peptide generated from catelicidin (125). Vitamin D might help to reduce the severity of inflammatory reactions by inhibiting pro-inflammatory cytokines (TNF-α and IL-6) which are associated in the development of cytokine storm in COVID-19 related ARDS (125, 137). In addition to its immune function, vitamin D, like Zn and vitamin C, is vital in the development and maintenance of epithelial and endothelial boundaries, including lung cell (125). According to several studies, there is a link between vitamin D insufficiency and SARS-CoV-2 infection susceptibility and clinical manifestations (125, 137). As a result, persons living in isolation need often subject themselves to direct sunlight and refill their dietary requirement of foods rich in vitamin D along with intake of vitamin D tablets commonly known as D-Rise tablet upon consultation of physicians, to maintain immune function. More clinical research is required to assess the effects of vitamin D supplementation in COVID-19 patients.

FIGURE 3

Figure 3 Role of vitamin D against COVID-19: It has an impact on SARS-CoV-2 infection outcomes through a variety of mechanisms, such as inducing anti-inflammatory effects and/or lowering neutrophil/lymphocyte ratio, provoking innate and acquired anti-viral responses, interacting with cellular factor ACE2, conversing with viral aspects, and/or disrupting virus life span.

Vitamin K is used for its cardiovascular health role, but scientists have revealed that it may also be advantageous for COVID-19 therapy. A new analysis by a team from the Bispebjerg Hospital in Denmark found that COVID-19 patients have low vitamin K levels and its deficiency is one variable that may imply higher death in patients (138). An investigation by Canisius Wilhelmina Hospital, researchers in the Netherlands, found that optimal levels of vitamin K play a pivotal role in blood clots and pulmonary dissuasion (139). These findings indicate that increased vitamin K intake may aid patients to combat COVID-19 better (93). Animal and plant sources for various vitamins are enlisted Supplementary Table 3.

Importantly, Vitamin A deficiency can cause osteoporosis if consumed in large amounts. This can increase the risk of fractures, especially in people who have already been diagnosed with osteoporosis (140). The high dose of vitamin E intake increasing lung cancer (141). The high dose of vitamin B absorbed increasing the growth of cancer cell (142). The high level of vitamin D is lower risk of breast cancer because it increased 25-hydroxyvitamin D (25-OH D) (143, 144).

There is no proven preventive technique to prevent the deadly COVID-19, a global issue where hydroxychloroquine (HCQ) was initially employed to counteract the COVID-19 viral load (145). Both the CQ and HCQ act as an immunomodulator. The clinical studies have found that in the COVID-19 patients, the increased concentration of cytokines in the plasma was observed (146). Remdesivir, an antiviral medication, prevented the virus from multiplying and was created to combat Ebola. The usage of this medicine aided the early recovery of the afflicted person. Because no medication has yet been discovered to be particularly successful against COVID-19, some antiviral drugs have been used in clinical research to treat COVID-19 patients (147, 148). Several drugs, including ribavirin, favipiravir, femdesivir, tenofovir, baricitinib, oseltamivir etc. are in trial phase (149, 150).

Limitation of Drugs That Used to Treat the COVID-19 Infection

There are currently no particular COVID-19 medications available however, several authorized drugs and novel antiviral compounds have been repurposed as prospective antiviral choices for COVID-19 infection treatment (151, 152). As a result, various pharmacological classes are being repurposed, including antivirals (like indinavir, ritonavir, saquinavir, darunavir, lopinavir, favipiravir, remdesivir, galidesivir, emtricitabin, tenofovir, oseltamivir, penciclovir, ganciclovir, ribavirin, umifenovir etc.), immunomodulators (like tocilizumab and interferon), enzyme inhibitors (like nafamostat, camostat and carfilzomib), anti-malarial (like chloroquine and hydroxychloroquine), anti-parasitic (ivermectin), anthelmintics (niclosamide), antibiotics (like teicoplanin, azithromycin,eravacycline, valrubicin, streptomycin, nitazoxanide, caspofungin, and colistin), anti-rheumatoid (like baricitinib), corticosteroids and herbal medicines (151–155). There are also several obstacles to overcome in terms of dose adjustments, acute/chronic toxicity, and unfavorable in vivo pharmacokinetic (PK) properties (e.g. plasma protein binding, tissue distribution, drug interactions), as well as the selection of an appropriate delivery system and method of exposure to deliver repurposed drugs against COVID-19 (151, 154). Another drawback of COVID-19 drug is that their proclivity for causing acute toxicity may surpass the uncertain benefit of a specific antiviral therapy (156). For example, the premature use of hydroxychloroquine in COVID-19 treatments may result severe skin lesions, liver failure, hypoglycemia, cardiovascular disorder, gastrointestinal upset, neuropsychiatric effects, and retinopathy, as well as an inferred significant threat of QT prolongation and ventricular arrhythmia in the case of its combination with azithromycin (153, 156–158). Antiviral drugs like lopinavir/ritonavir/remdesivir/favipiravir have been linked to nausea, diarrhea, hepatotoxicity, vomiting, gastroparesis, or rectal bleeding, abnormal liver function, renal impairment, higher serum uric acid, hypotension, and rashes, whereas ribavirin, also known as a teratogen and contraindicated in pregnancy causes severe dose-dependent hematologic toxicity including hemolyticanemia (61%), hypocalcemia (58%), and hypomagnesemia (46%) (156, 158, 159). Other drugs that have been reported to have side effects include fever, myalgias, headaches, leukopenia, lymphopenia, autoimmune hepatitis, and thyroid disease for interferon, upper respiratory tract infection, malignancy, thrombosis, nausea, blurred vision, hypocholesterolemia, hypertension, urinary tract infection and skin cancer for baricitinib,and are nausea, rashes, dizziness, fever and tachycardia for ivermectin (158, 159). Likewise, many other drugs are also linked to a variety of side effects, and further research in needed to confirm their therapeutic usefulness (153). In immune-compromised individuals, the emergence of viral resistance, viral dormancy, and recurrent infection is a downside of antimalarial drugs, whereas oral dosing of niclosamide is a limitation in its capacity to reach the infection site due to poor absorption (97, 154). The use of corticosteroids is still debated, and current World Health Organization guidelines advise against using them unless there is some concurrent indication, such as chronic obstructive pulmonary disease exacerbation or pressor-refractory shock (156). Some of the drawbacks of medicinal plants include a lack of information on the safety profile and dosage for various ailments (155). There are still no well-designed PK and pharmacokinetic-pharmacodynamic (PK-PD) data of COVID-19 patients available, as well as no high-quality evidence to support the use of the above repurposed medications for COVID-19 treatment. As a result, well-designed PK and PD studies particularly targeting COVID-19 patients are immediately needed to improve our understanding of the repurposed medicines’ dose-exposure-effect correlations (151).

Food Supplements Play Important Role in Immunity Boost Up

Probiotics prevent respiratory tract infections like coronavirus infection, a research study showed that supplementation with Bifidobacterium breve YIT4064 augments the antibody response against oral influenza virus and producesa significantly greater amount of high serum anti-influenza virus-specific IgG (160). Supplementation with Lactobacillus casei also conferred significantly increased protection to the upper respiratory infection by intra-nasal influenza virus (161). Another study performed on children aged 1-6 years, who were fed with milk supplemented with Lactobacillus rhamnosus showed a lower incidence of respiratory tract infections compared to the control group (162).

Honey, another widely used food supplement potentiate to augment the innate immune system and may help fight against COVID-19 (163). It has been found to cause cell division (mitosis) in both B- and T-cells (164). Because it can activate T-lymphocytes, B-lymphocytes, and neutrophils, leading to the production of cytokines. Therefore, it plays a crucial role in generating an adaptive immune response to SARS-CoV-2 (165). Sugars, organic acids, amino acids, phenolic compounds, vitamins, and minerals are among the components found in honey. This is why honey has been researched in animal and human models for a long time to determine its antioxidant potency (165–167). Honey has also been shown to reduce acute respiratory distress symptoms when consumed daily (168).

Zinc (Zn), is an essential trace element, also known as the “magic bullet,” that is required for the normal human cell activity, the protection of normal tissue barriers including the respiratory epithelium, inhibiting pathogen invasion, and a healthy immune and redox systems (169). Its potent immunoregulatory and antiviral properties, as well as its importance in growth, reproduction, immunity, and neurobehavioral development, have made this mineral and its ionophores potential COVID-19 targets (59, 125, 170). Zn has the ability to increase T cell growth and activity, so decreasing the cytokine storm, which is characterized by high amounts of proinflammatory cytokines and chemokines that cause systemic immune response dysfunction, resulting in ARDS or multiple organ failure (125). It also contributes to the integrity of epithelial barriers, which are necessary for organism defense and pathogen invasion prevention (59, 125). Several studies have looked into the role of Zn in immunity and host susceptibility and its insufficiency is most likely one of the variables that predisposes people to infection and advancement of COVID-19 (169, 171). In vitro tests found that the Zn ionophore pyrrolidine dithiocarbamate inhibited influenza virus replication, and that modest doses of Zn and Zn-pyrithione limit SARS-CoV-1 replication by inhibiting RNA polymerase, which is required for RNA virus replication (59, 125, 137, 172, 173). Zn can also improve interferon (IFN) cytokine signalling against RNA viruses and reduce angiotensin-converting enzyme 2 (ACE2) activity, which is required for SARS-CoV-2 entrance into host cells (125). Zn, as a result, suppresses the elongation phase of RNA transcription. Further, it may boost antiviral immunity by increasing IFNα levels in leukocytes via JAK/STAT1 signaling pathway (173). A recent in vitro study found that low zinc levels promote viral growth in SARS-CoV-2 infected cells while, in a complete metal(loid)s investigation, the amount of Zn, Mg, manganese, iron, lead, arsenic, and thallium was lower in severe COVID-19 patients compared to non-COVID-19 patients (174, 175). Consequently, control trial and meta-analyzed data revealed that a significant number of COVID-19 patients were Zn deficient (88, 175), which was associated with a longer hospital stay and increased mortality, whereas, Zn treatment has been reported to reduce the severity (up to 54%) and duration of various cold symptoms, such as fever, cough, sore throat, muscle pain and nasal congestion (88),which can occur after SARS-CoV-2 infection as well as decreased pneumonia in infants, and decreased mortality (59, 123). Although it is unknown whether Zn supplementation can help patients with lower respiratory tract infections, because of its direct antiviral activity, it may alleviate tissue injury caused by mechanical ventilation in COVID-19 patients who are critically ill with low Zn level, and it may be used in conjunction with antiviral drugs to treat COVID-19 infection (169, 173). Zn is now being explored for prophylaxis and treatment of COVID-19 patients due to its role in immune function and ability to limit coronavirus replication. The usual dose for Zn varies (2-13 mg/day), irrespective of age and sex, with the upper safety threshold for Zn is set at 40 mg/day by the Institute of Medicine (IOM), and it is worth emphasizing that prior to taking Zn, physicians’ advice should be asked to mitigate deleterious consequences (175).With more investigation, it might provide a cost-effective therapy for COVID-19, which is obviously needed in this pandemic.

Magnesium (Mg) as an enzymatic activator that plays a role in a variety of physiological activities including cell cycle, metabolic regulation, muscle contraction, and vasomotor tone, as well as anti-inflammation, anti-oxidation, immunological response, anti-spasm, vasodilation, and neuroprotection (176, 177). Mg is a necessary cofactor for oxidative phosphorylation, energy production, protein synthesis, glycolysis, and nucleic acid synthesis and maintenance, among other biological activities (approximately 600) (178, 179). It functions as a structural or catalytic component on enzymes as well as on substrates and it is required for oxidative phosphorylation, energy production, protein synthesis, glycolysis, and nucleic acid synthesis and maintenance (178). As a result, it significantly supports the hypothesis that magnesium deficiency may influence SARS-CoV-2 susceptibility and response. Mg sulfate, a calcium antagonist, is often utilized as a bronchodilator in the adjuvant treatment of asthmatic patients (178). By blocking the IL-6, NF-kB, and L-type calcium channels, it also reduces inflammatory responses and oxidative stress, as well as improving lung inflammation (178). Accordingly, Mg sulfate has a promising aspect in the treatment of pulmonary symptoms, with the potential to reduce respiratory distress and enhance lung function in COVID-19 patients. There is insufficient information on the magnesium status of people with Covid-19 of various severity levels. According to a retrospective study, lower Mg levels were seen in patients with more severe COVID-19 symptoms (61). In a recent transversal investigation, hypomagnesemia was found to be common in hospitalized Covid-19 patients, but high-level serum magnesium concentration was more frequent in critical condition (176). Surprisingly, Mg deficiency has been recorded in up to 60% of critically ICU patients, predisposing these patients to serious, even life-threatening effects such as hypokalemia and hypocalcemia (178). According to a cohort research, the combination oral treatment of Mg (150 mg daily), vitamin D (1000 IU daily), and vitamin B12 (500 mcg daily) considerably decreases the proportion of older COVID-19 patients who need oxygen and/or critical care support (180). In fact, Mg sulfate prolonged infusion could be used as a supplement to other treatments for COVID-19-infected severely ill individuals. Mg and vitamin D are required for the immunological function and cellular resilience in a variety of organs. In particular, Mg aids in the synthesis of vitamin D, which helps to control calcium and phosphate equilibrium to impact bone formation and maintenance (61, 178). A lack of either these nutrients has been linked to a variety of ailments, including skeletal abnormalities, cardiac diseases, and metabolic disorders, as well as the cytokine storm seen in the COVID-19 infection (179, 181). In a group of COVID-19 patients, oral therapy with Mg, vitamin D, and vitamin B12 reduced the need for oxygen assistance, intensive care admission, or both (180). Hence, it is prudent to address not only vitamin D deficiency but also Mg deficiency and in COVID-19 patients, the prescribed dose of Mg (Supplementary Table 4) need to be taken in order to achieve the most advantages of Vitamin D (178, 179). Of obviously, given the unique circumstances surrounding the COVID-19 epidemic, extensive clinical data is necessary in future study to determine whether Mg sulfate in combination with other approved therapeutic medicines is more useful to COVID-19 patients’ health.

Copper’s role in immunity and host susceptibility to infection is proved in several studies (24, 182, 183). A recent study at the University of Southampton has revealed that copper can successfully inhibit the proliferation of respiratory viruses, such as those associated with SARS and MERS outbreaks (184, 185). It would be worth exploring the implementation of the same strategy against COVID-19. The absence of copper in the body leads to lower IL-2 proliferation and also lowers the potential to generate superoxide anion and destroy microorganisms that have been ingested (24). Some food can be used as a source of copper as oysters, nuts, seeds, chicken marinated mushrooms, lobster, liver, leafy greens, and dark chocolate (121). It enhances the reaction of T lymphocytes, such as replication and IL-2 secretion (186).

Selenium is yet another micronutrient that has an important role to play when it comes to maintaining human health. Selenium impacts all the immune responses– innate, non-adaptive, and adaptive (187). Food rich in selenium includes beef, turkey, chicken, seafood, shellfish, and eggs (121). It enhances immune cell production against various pathogens (187–189). The low levels of selenium decrease the activity of the natural killer cell and increased mycobacterial disease (189, 190). It can improve various aspects of human immune function (100 - 300 μg/day), including older adults (191).

Beta-glucans contribution in promoting stimulation against viral attack has been demonstrated in numerous human trials (192, 193). Results of several studies have shown a reduction in cold and flu symptoms and upper respiratory infections when compared to placebo. The mechanism of action of beta-glucans against viruses other than COVID-19 might be promoting viral elimination or inhibition by priming innate immune function (194). Recent studies show the possibility of both a prophylactic and a curative advantage of sulforaphane against ARDS and SARS-CoV-2 (195, 196).

The supplements mentioned above may have immune-boosting properties, according to the outcome of scientific studies. However, several of these supplements have not been extensively tested in humans, emphasizing the need for future research.

Immunity-Boosting Properties of Different Metabolites Against COVID-19

Metabolites are those small molecules that are intermediate or end products of metabolism. They have a wide variety of functions, including- signalling, stimulatory and inhibitory effects on enzymes, modulating the immune response, catalytic activity of their own, defense, and interactions with other organisms. Metabolites are used to regulate the growth, differentiation, and activity of the immune system (197). As of now, it is known that COVID-19 impairs those human subjects whose immune system is not efficient enough to fight viral infection. In that case, metabolites can enhance the immune system to counteract viral infection. SARS-CoV-2 has also been reported for manipulating the balance and secretion of metabolites in the host to facilitate their replication process (198), the mechanism of which has been depicted in Figure 4.

FIGURE 4

Figure 4 Modification of some metabolic pathways due to viral infection. Human cell metabolism systems alter by viral infection as they rely on host cell machinery to multiply; viruses promote human anabolism for the generation of macromolecules for replication and assembly. *Herpes-virus family; #Flavivirus family; **down-regulates this metabolic activity; ##up-regulates lipid synthesis but down-regulates cholesterol synthesis (199).

Some anaerobic commensal bacteria in the cecum and colon produces short-chain fatty acids (SCFAs) (e.g., acetate, propionate, butyrate, etc.) where some Bacteroidetes were reported to produce acetate and propionate, butyrate is primarily made by certain Firmicutes (200). Administration of SCFAs alters hematopoiesis to increase the myeloid output, which eventually aids in clearing systemic infections and alleviates allergic reactions (201).

Tryptophan, a substrate for microbial metabolism, produces indole-3-aldehyde, a ligand for the aryl hydrogen receptor (AhR) (202). In this way, it enhances immune maturation at the tissuelevel. AhR expression is required for the expansion of RORγt+ group 3 innate lymphoid cells (ILC3s) (203). It is also pivotal for maintaining the epithelial barrier and homeostasis of intraepithelial lymphocytes (IELs) (204).

Long-chain polyunsaturated fatty acids (PUFAs) have important roles in inflammatory and adaptive immune responses. In most situations, omega-3 and omega-6 PUFAs promote anti-inflammatory and proinflammatory action (205). Furthermore, protein D1, a lipid mediator generated from omega-3 PUFA, may dramatically decrease influenza virus proliferation via RNA export machinery (206). Food sources for Omega-3 polyunsaturated fatty acids (PUFAs) (114) are- meat, poultry, cereal-based products, milk products, vegetables, savory sauces and condiments, sugar products and dishes, and special dietary foods.

The Thymosin alpha 1 (Tα1) is a peptide that consists of 28 amino acids (thymalfasin, trade name ZADAXIN ^®) (207). The amino acid series is homologous in bovine, murine, and human species and a chemical-synthesized version demonstrated close behavior to the native peptide in T-cell maturation modulation (208). Tα1 can influence the mobilization of pre-NK cells that then become cytotoxic following interferon exposure. It has an unusual capacity to maintain the homeostasis of the immune system. Tα1 can also be used as an immune stimulator in SARS patients, and it has successfully managed disease spread (209).

Thymopentin is a pentapeptide generic metabolite having the active site of the naturally found thymopoietin hormone and has immune amplifying effects. It increases thymic T cell development and may help regain immunocompetence in immunosuppressed subjects (210). Myristic acid-modified thymopentin for improved plasma stability and immunomodulation (211). Thymopentin may also be a good alternative for handling this novel coronavirus by improving the immune system.

Levamisole is a synthetic low-molecular-weight organic compound, that can improve immunity. However, levamisole may function either as an immune stimulant or an immunosuppressant depending on the dose and timing. Levamisole and in vitro ascorbic acid therapy may restore the lymphocyte subpopulation of the distressed helper/inducer in measles (212). Therefore, the use of levamisole could also be considered for COVID-19 treatment.

Cyclosporine is a cyclic peptide with an immunosuppressive preferential action. Cyclosporine A is used to cure inflammatory diseases. It has played a significant role in viral infection, either promoting or inhibiting their replication (213). Additionally, cyclosporine A prevents replication of all genera of coronavirus, including SARS-CoVs and avian infectious bronchitis virus (214). Therefore, the non-immunosuppressive variants of cyclosporine A may act as broad-range coronavirus inhibitors that are relevant against the new novel virus such as SARS-CoV-2.

Personal Habits as a Key Tool to Rejuvenate the Immune System

Exercise or physical activity is like a safe living medication for chronic illness prevention, recovery, and also proper maintenance of physical and mental condition (52). Routine exercise has demonstrated an improved response to antioxidants that can increase immunosurveillance (Figure 5) (215). IL-6, which has an anti-inflammatory function, also partly mediates the immunomodulating effect of exercise (216). The metabolic activity is also associated with daily workouts, including developments in glucose metabolism, lipids, and insulins, and as an adjuvant to immune and metabolic help (217). Physical activity has also been found to alleviate many viral infections, like- influenza, rhinovirus, and herpes viruses like herpes simplex virus 1 (HSV-1), varicella-zoster (VZV), and Epstein-Barr virus (EBV) (218, 219). Moreover, World Health Organization (WHO) has already proposed a guideline that suggests a certain amount of exercises such as walking, breathing for the people who have no symptoms or diagnosis of acute respiratory illness during self-quarantine (220).

Sleep, according to several studies, sleep plays a vital role in the uplift of the immune system (42, 53). Furthermore, when people do not get enough sleep, their antibodies and defensive cells are decreased (221). Sleeping time is closely associated with gender, age, and physical activity, with the ideal, suggested sleep length in adults often ranging between 7 and 9 hours each night (222). In a recent study, 164 individuals took a dose of the common cold and then followed up on their sleeping patterns. The findings revealed that those who have slept for less than six hours a night are more susceptible than those who have slept for more than seven hours to establish cold symptoms, and like so, having enough sleep could help us against the COVID-19 (223). The study indicates that cold and influenza-infected individuals experience worse symptomatic conditions when they sleep badly. This happens may be due to high proinflammatory cytokines, which intervene with T-cells as well as other immune cells (221).

Intermittent Fasting (IF) has been found to affect immunity through changes in various associated components, such as oxidative stress and inflammation, metabolism, weight gain, and feed structure. This food restriction technique can be implemented directly (by the activation of the immune response) (54) or indirectly (through autophagy induction) (224, 225) or by stimulating body monitoring systems and enhancing immunity to cope with stress thus promoting host protection. IF aids in the normalization of the body’s systemic inflammatory status by restricting proinflammatory cytokines (IL-1, IL-6, and TNF-α) (226). Fasting also up regulates gene expression of cytokines type 2 (Il-4, Il-5, and Il-13), crucial for M2 macrophage polarisation (anti-inflammatory) (227). Furthermore, IF can also modulate the potential SARS-CoV-2 immune evading mechanism, which involves ORF3a viral-mediated persistent activation of the NLRP3. Despite being supported by several experimental test results; robust studies are still in need to prove the potential of regulated fasting for the improvement of immunity.

Alkaline diet, the diet or culinary element with a low net potential renal acid load (PRAL) is regarded as an alkaline diet that causes mild alkalosis in the blood, which denatures the virus and helps to control the infection (228). Fruits (raisins, oranges, strawberries, watermelons), juices (apple, lemon, grape) vegetables (spinach, carrot, cabbage, celery, cauliflower, cucumber, radish, green capsicum, tomatoes) milk products (curd, buttermilk) all have a very low PRAL value and have been reported to be effective anti-influenza agents. Current evidence indicates that an alkaline diet can help improve resistance and may even play a role in COVID-19 treatments (229). It raises cellular pH (especially in respiratory cells), preventing viral nucleic acid from reaching the cytoplasm and hence preventing growth and spread (196). Alkaline diets or drinks cause decreased metabolic alkalosis in the cytoplasmic pH of respiratory tract cells, which eventually raises the pH of the endosome, disrupting the viral life cycle in the early phases and partially assisting in the development of physiological resistance to viral infection (229). Nitric Oxide (NO) inhibits viral protein and RNA, as well as NO synthase reduces progeny virus output by 82%, reducing corona virus replication by virtue of its antiviral impact. It is hypothesized that, in addition to humming, eating alkaline meals high in dietary nitrates, which the body can convert to NO, boosts NO expression and carbon dioxide through longer expiration, preventing coagulopathies and morbidity caused by COVID-19 (230). Fresh juice free of preservatives from the aforementioned vegetables, or antioxidants derived from purple carrot and cabbage, in combination with appropriate anti-coagulants, may help prevent or mitigate the negative effects of COVID-19 pathological outcomes, as well as mitigate multi-organ damage caused by COVID-19 during the ongoing pandemic (231).

Mental Health and Immunity

Stress, worry, depressive symptoms (Figure 5), sleeplessness, denial, rage, and terror are among the mental health concerns linked to the COVID-19 pandemic (232) where in some cases COVID-19 may lead to suicide (233–235). During the COVID-19 epidemic, a group of people relies on electronic devices and social media, which upsurges the risk of stress, worry, and anxiety (113, 139). Children and young people, in particular, have limited access to open spaces and playgrounds, owing to their increased reliance on electronic devices such as cell phones. These circumstances have the potential to result in serious mental disorders in the future (236, 237). Researchers should start psychological examinations to detect mental health issues to give early treatment and psychological help. To improve mental health condition, WHO recommended some guidelines to eat a healthy and nutritious diet, limit alcohol consumption, avoid sugary drinks, avoid smoking, 30 minutes physical exercise, listen to music, read the book or play a game (https://www.who.int/).

FIGURE 5

Figure 5 Symptoms of depression for COVID-19 patients. COVID-19 has changed emotions, behaviours, thoughts, and physical condition. Anxiety and stress are the common outcomes in pandemics.

Conclusion

An immunostimulant host, rather than a susceptible one, can assure a robust immune system that can fight against COVID-19 infection as well as other viruses or bacteria, by eating a nutritious diet, sleeping well, and exercising often. People who eat a well-balanced diet appear to have a stronger immune system and a lower risk during COVID-19 infection. COVID-19, like many other viral diseases, poses a plethora of challenges to deal with using conventional anti-viral drugs or newly developed vaccines. Hence, a healthy and active immune system is the sole most important factor that can truly help us in the battle of COVID-19 during this global pandemic. Factors like the inclusion of vege`s and fruits in daily diet, medicinal plants and herbs, vitamins, metabolites, probiotics, potential antiviral drugs, and physical exercise to gain a more protective immune response against SARS-CoV-2 have been briefly discussed throughout this review. These elements of boosting immunity can be easily implemented into the daily lifestyle & regular habits that will ultimately ensure a healthy immune system. Besides, It is necessary to move forward with research into the development of potential COVID-19 drugs and vaccines.

This review clearly demonstrates that adequate nutraceuticals and phytochemicals derived from a variety of plant or herb sources can boost up against COVID-19 infection. Therefore, a lack of immunity intensifiers can be detrimental to the immune system. To summarize, the simplest approach to strengthen the immune system is to consume nutrients that act as immunity boosters, and phytochemicals are the best after nutrients, and both can be utilized as a potent weapon against SARS-CoV-2.

Author Contributions

MI and MAH: Writing original draft, review, and editing. MAR, FH, MR and AB: Literature review and editing. AM, TD and SB: Construct figures, tables and data curation. CH and FA: Conceptualization, review, and editing. PB and MJ: Preparing response to the reviewers and involve resource management. All authors contributed to the article and approved the submitted version.

Funding

This study was funded through a seed grant from the Life Sciences Platform and KTH Water Center, KTH Royal Institute of Technology, Stockholm, Sweden and institutional grants from North South University, Dhaka, Bangladesh and Noakhali Science and Technology University, Noakhali, Bangladesh.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

The authors acknowledge Arif Main Uddin, Arif Roman, Ali Hossain, Raihan Uddin, Turasa Nahla for their suggestions in writing manuscript.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2022.837290/full#supplementary-material

References

1. Kahn JS, McIntosh K. History and Recent Advances in Coronavirus Discovery. Pediatr Infect Dis J (2005) 24:223–7. doi: 10.1097/01.inf.0000188166.17324.60

CrossRef Full Text | Google Scholar

2. Mahase E. Covid-19: Coronavirus was First Described in The BMJ in 1965. BMJ (2020) 369:m1547. doi: 10.1136/bmj.m1547

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Woodhead M, Ewig S, Torres A. Severe Acute Respiratory Syndrome (SARS). Eur Respir J (2003) 21:739–40. doi: 10.1183/09031936.03.00035403

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Remembering SARS: A Deadly Puzzle and the Efforts to Solve It. Centers for Disease Control and Prevention. CDC. 26 Apr. 2013. Available at: http://www.cdc.gov/about/history/sars/feature.htm

Google Scholar

5. WHO. Coronavirus Never Before Seen in Humans is the Cause of SARS N.D. World Health Organization (2003). Available at: https://www.who.int/news/item/16-04-2003-update-31---coronavirus-never-before-seen-in-humans-is-the-cause-of-sars.

Google Scholar

6. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJM, Wolthers KC, et al. Identification of a New Human Coronavirus. Nat Med (2004) 10:368–73. doi: 10.1038/nm1024

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a Novel Coronavirus From a Man With Pneumonia in Saudi Arabia. N Engl J Med (2012) 367:1814–20. doi: 10.1056/NEJMoa1211721

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Wang C, Horby PW, Hayden FG, Gao GF. A Novel Coronavirus Outbreak of Global Health Concern. Lancet (2020) 395:470–3. doi: 10.1016/S0140-6736(20)30185-9

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med (2020) 35:1545–9. doi: 10.1007/s11606-020-05762-w

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Fontanet A, Autran B, Lina B, Kieny MP, Karim SSA, Sridhar D. SARS-CoV-2 Variants and Ending the COVID-19 Pandemic. Lancet (2021) 397:952–4. doi: 10.1016/S0140-6736(21)00370-6

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, et al. The N501Y Spike Substitution Enhances SARS-CoV-2 Transmission. bioRxiv Preprint (2021) 602:294–9. doi: 10.1101/2021.03.08.434499

CrossRef Full Text | Google Scholar

12. Wong NA, Saier MH. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis. Int J Mol Sci (2021) 22:1308. doi: 10.3390/ijms22031308

PubMed Abstract | CrossRef Full Text | Google Scholar

13. V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus Biology and Replication: Implications for SARS-CoV-2. Nat Rev Microbiol (2021) 19:155–70. doi: 10.1038/s41579-020-00468-6

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Parasher A. COVID-19: Current Understanding of its Pathophysiology, Clinical Presentation and Treatment. Postgrad Med J (2021) 97:312–20. doi: 10.1136/postgradmedj-2020-138577

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, et al. Insights to SARS-CoV-2 Life Cycle, Pathophysiology, and Rationalized Treatments That Target COVID-19 Clinical Complications. J BioMed Sci (2021) 28:9. doi: 10.1186/s12929-020-00703-5

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 Infection: Origin, Transmission, and Characteristics of Human Coronaviruses. J Adv Res (2020) 24:91–8. doi: 10.1016/j.jare.2020.03.005

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Yashavantha RHC, Chelliah J. The Emergence of a Novel Coronavirus (SARS-CoV-2) Disease and Their Neuroinvasive Propensity may Affect in COVID-19 Patients. J Med Virol (2020) 92:786–90. doi: 10.1002/jmv.25918

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Yin W, Mao C, Luan X, Shen D-D, Shen Q, Su H, et al. Structural Basis for Inhibition of the RNA-Dependent RNA Polymerase From SARS-CoV-2 by Remdesivir. Science (2020) 368:1499–504. doi: 10.1126/science.abc1560

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Pokhrel R, Chapagain P, Siltberg-Liberles J. Potential RNA-Dependent RNA Polymerase Inhibitors as Prospective Therapeutics Against SARS-CoV-2. J Med Microbiol (2020) 69:864–73. doi: 10.1099/jmm.0.001203

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Adhikari P, Li N, Shin M, Steinmetz NF, Twarock R, Podgornik R, et al. Intra- and Intermolecular Atomic-Scale Interactions in the Receptor Binding Domain of SARS-CoV-2 Spike Protein: Implication for ACE2 Receptor Binding. Phys Chem Chem Phys (2020) 22:18272–83. doi: 10.1039/D0CP03145C

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Schoeman D, Fielding BC. Coronavirus Envelope Protein: Current Knowledge. Virol J (2019) 16:69. doi: 10.1186/s12985-019-1182-0

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Singh E, Khan RJ, Jha RK, Amera GM, Jain M, Singh RP, et al. A Comprehensive Review on Promising Anti-Viral Therapeutic Candidates Identified Against Main Protease From SARS-CoV-2 Through Various Computational Methods. J Genet Eng Biotechnol (2020) 18:69. doi: 10.1186/s43141-020-00085-z

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Goyal B, Goyal D. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy. ACS Comb Sci (2020) 22:297–305. doi: 10.1021/acscombsci.0c00058

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Huang C, Wang Y, Li X, Ren L, Hu Y, Hu Y, et al. Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. Lancet (2020) 395:497–506. doi: 10.1016/S0140-6736(20)30183-5

CrossRef Full Text | Google Scholar

25. Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19): The Epidemic and the Challenges. Int J Antimicrob Agents (2020) 55:105924. doi: 10.1016/j.ijantimicag.2020.105924

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet (2020) 395:507–13. doi: 10.1016/S0140-6736(20)30211-7

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med (2020) 382:1708–20. doi: 10.1056/NEJMoa2002032

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Forni G, Mantovani A. COVID-19 Vaccines: Where We Stand and Challenges Ahead. Cell Death Differ (2021) 28:626–39. doi: 10.1038/s41418-020-00720-9

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Forni G, Mantovani A, Moretta L, Rezza G. Vaccines. Accademia Nazionale dei Lincei (2018). Available at: https://www.lincei.it/it/article/i-vaccini-vaccines-position-paper.

Google Scholar

30. Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV Viral Load Dynamics, Duration of Viral Shedding, and Infectiousness: A Systematic Review and Meta-Analysis. Lancet Microbe (2021) 2:e13–22. doi: 10.1016/S2666-5247(20)30172-5

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Rahman MA, Islam MS. Early Approval of COVID-19 Vaccines: Pros and Cons. Hum Vaccin Immunother (2021) 17:3288–96. doi: 10.1080/21645515.2021.1944742

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Pathan RK, Biswas M, Khandaker MU. Time Series Prediction of COVID-19 by Mutation Rate Analysis Using Recurrent Neural Network-Based LSTM Model. Chaos Solitons Fractals (2020) 138:110018. doi: 10.1016/j.chaos.2020.110018

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Chen J. Should the World Collaborate Imminently to Develop Neglected Live-Attenuated Vaccines for COVID-19? J Med Virol (2022) 94:82–7. doi: 10.1002/jmv.27335

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Rosen B, Waitzberg R, Israeli A, Hartal M, Davidovitch N. Addressing Vaccine Hesitancy and Access Barriers to Achieve Persistent Progress in Israel’s COVID-19 Vaccination Program. Isr J Health Policy Res (2021) 10:43. doi: 10.1186/s13584-021-00481-x

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, et al. Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial. Science (2022) 375:43–50. doi: 10.1126/science.abm3425

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Wang J, Pan L, Tang S, Ji JS, Shi X. Mask Use During COVID-19: A Risk Adjusted Strategy. Environ Pollut (2020) 266:115099. doi: 10.1016/j.envpol.2020.115099

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Lee C, Chen Y, Wu P, Chiou W. An Unintended Consequence of Social Distance Regulations: COVID-19 Social Distancing Promotes the Desire for Money. Br J Psychol (2021) 112:866–78. doi: 10.1111/bjop.12497

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Khan MH, Yadav H. Sanitization During and After COVID-19 Pandemic: A Short Review. Trans Indian Natl Acad Eng (2020) 5:617–27. doi: 10.1007/s41403-020-00177-9

CrossRef Full Text | Google Scholar

39. Arenas MD, Villar J, González C, Cao H, Collado S, Crespo M, et al. Management of the SARS-CoV-2 (COVID-19) Coronavirus Epidemic in Hemodialysis Units. Nefrol (2020) 40:258–64. doi: 10.1016/j.nefroe.2020.04.001

CrossRef Full Text | Google Scholar

40. Gershoff SN, Vitamin C. (Ascorbic Acid): New Roles, New Requirements? Nutr Rev (2009) 51:313–26. doi: 10.1111/j.1753-4887.1993.tb03757.x

CrossRef Full Text | Google Scholar

41. Wahlstrom KL, Berger AT, Widome R. Relationships Between School Start Time, Sleep Duration, and Adolescent Behaviors. Sleep Heal (2017) 3:216–21. doi: 10.1016/j.sleh.2017.03.002

CrossRef Full Text | Google Scholar

42. Besedovsky L, Lange T, Born J. Sleep and Immune Function. Pflügers Arch - Eur J Physiol (2012) 463:121–37. doi: 10.1007/s00424-011-1044-0

CrossRef Full Text | Google Scholar

43. Nizami NS, Uddin CSM. Strong Immunity- A Major Weapon to Fight Against Covid-19. IOSR J Pharm Biol Sci (2020) 15:22–29. doi: 10.9790/3008-1503032229

CrossRef Full Text | Google Scholar

44. Calder PC. Nutrition, Immunity and COVID-19. BMJ Nutr Prev Heal (2020) 3:74–92. doi: 10.1136/bmjnph-2020-000085

CrossRef Full Text | Google Scholar

45. Bhaskaram P. Immunobiology of Mild Micronutrient Deficiencies. Br J Nutr (2001) 85:S75–80. doi: 10.1079/bjn2000297

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Wintergerst ES, Maggini S, Hornig DH. Contribution of Selected Vitamins and Trace Elements to Immune Function. Ann Nutr Metab (2007) 51:301–23. doi: 10.1159/000107673

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus Infections and Immune Responses. J Med Virol (2020) 92:424–32. doi: 10.1002/jmv.25685

PubMed Abstract | CrossRef Full Text | Google Scholar

48. de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol (2018) 419:1–42. doi: 10.1007/82_2017_25

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Deeks SG, Odorizzi PM, Sekaly RP. The Interferon Paradox: Can Inhibiting an Antiviral Mechanism Advance an HIV Cure? J Clin Invest (2017) 127:103–5. doi: 10.1172/JCI91916

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Channappanavar R, Zhao J, Perlman S. T Cell-Mediated Immune Response to Respiratory Coronaviruses. Immunol Res (2014) 59:118–28. doi: 10.1007/s12026-014-8534-z

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019. J Clin Invest (2020) 130:2620–9. doi: 10.1172/JCI137244

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Fletcher GF, Landolfo C, Niebauer J, Ozemek C, Arena R, Lavie CJ. Promoting Physical Activity and Exercise: JACC Health Promotion Series. J Am Coll Cardiol (2018) 72:1622–39. doi: 10.1016/j.jacc.2018.08.2141

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Lange T, Dimitrov S, Born J. Effects of Sleep and Circadian Rhythm on the Human Immune System. Ann N Y Acad Sci (2010) 1193:48–59. doi: 10.1111/j.1749-6632.2009.05300.x

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Cheng C-W, Adams GB, Perin L, Wei M, Zhou X, Lam BS, et al. Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression. Cell Stem Cell (2014) 14:810–23. doi: 10.1016/j.stem.2014.04.014

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, D.C: National Academies Press (2005). doi: 10.17226/10490

CrossRef Full Text | Google Scholar

56. Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, D.C: National Academies Press (2005). doi: 10.17226/10925

CrossRef Full Text | Google Scholar

57. EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA). Scientific Opinion on Dietary Reference Values for Water. EFSA J (2010) 8:1–48. doi: 10.2903/j.efsa.2010.1459

CrossRef Full Text | Google Scholar

58. Huang Z, Liu Y, Qi G, Brand D, Zheng S. Role of Vitamin A in the Immune System. J Clin Med (2018) 7:258. doi: 10.3390/jcm7090258

CrossRef Full Text | Google Scholar

59. Shankar AH, Prasad AS. Zinc and Immune Function: The Biological Basis of Altered Resistance to Infection. Am Soc Nutr (1998) 68:447S–63S. doi: 10.1093/ajcn/68.2.447S

CrossRef Full Text | Google Scholar

60. Fraker PJ, King LE, Laakko T, Vollmer TL. The Dynamic Link Between the Integrity of the Immune System and Zinc Status. J Nutr (2000) 130:1399S–406S. doi: 10.1093/jn/130.5.1399S

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Zeng HL, Yang Q, Yuan P, Wang X, Cheng L. Associations of Essential and Toxic Metals/Metalloids in Whole Blood With Both Disease Severity and Mortality in Patients With COVID-19. FASEB J (2021) 35:1–12. doi: 10.1096/fj.202002346RR

CrossRef Full Text | Google Scholar

62. Bayan L, Koulivand PH, Gorji A. Garlic: A Review of Potential Therapeutic Effects. Avicenna J Phytomedicine (2014) 4:1–14. doi: 10.22038/ajp.2014.1741

CrossRef Full Text | Google Scholar

63. Arreola R, Quintero-Fabián S, López-Roa RI, Flores-Gutiérrez EO, Reyes-Grajeda JP, Carrera-Quintanar L, et al. Immunomodulation and Anti-Inflammatory Effects of Garlic Compounds. J Immunol Res (2015) 2015:1–13. doi: 10.1155/2015/401630

CrossRef Full Text | Google Scholar

64. Donma MM, Donma O. The Effects of Allium Sativum on Immunity Within the Scope of COVID-19 Infection. Med Hypotheses (2020) 144:1–5. doi: 10.1016/J.MEHY.2020.109934

CrossRef Full Text | Google Scholar

65. Rasool A, Khan M-U-R, Ali MA, Anjum AA, Ahmed I, Aslam A, et al. Anti-Avian Influenza Virus H9N2 Activity of Aqueous Extracts of Zingiber Officinalis (Ginger) and Allium Sativum (Garlic) in Chick Embryos. Pak J Pharm Sci (2017) 30:1341–4.

PubMed Abstract | Google Scholar

66. Chang JS, Wang KC, Yeh CF, Shieh DE, Chiang LC. Fresh Ginger (Zingiber Officinale) has Anti-Viral Activity Against Human Respiratory Syncytial Virus in Human Respiratory Tract Cell Lines. J Ethnopharmacol (2013) 145:146–51. doi: 10.1016/j.jep.2012.10.043

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Arora R, Chawla R, Marwah R, Arora P, Sharma RK, Kaushik V, et al. Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud. Evid Based Complement Alternat Med (2011) 2011:1–16. doi: 10.1155/2011/586506

CrossRef Full Text | Google Scholar

68. Tripathi S, Bruch D, Kittur DS. Ginger Extract Inhibits LPS Induced Macrophage Activation and Function. BMC Complement Altern Med (2008) 8:1. doi: 10.1186/1472-6882-8-1

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Pilau MR, Alves SH, Weiblen R, Arenhart S, Cueto AP, Lovato LT. Antiviral Activity of the Lippia Graveolens (Mexican Oregano) Essential Oil and its Main Compound Carvacrol Against Human and Animal Viruses. Braz J Microbiol (2011) 42:1616–24. doi: 10.1590/S1517-83822011000400049

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Sharifi-Rad J, Salehi B, Schnitzler P, Ayatollahi SA, Kobarfard F, Fathi M, et al. Susceptibility of Herpes Simplex Virus Type 1 to Monoterpenes Thymol, Carvacrol, P-Cymene and Essential Oils of Sinapis Arvensis L., Lallemantia Royleana Benth. And Pulicaria Vulgaris Gaertn. Cell Mol Biol (2017) 63:42–7. doi: 10.14715/cmb/2017.63.8.10

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Mondal S, Varma S, Bamola VD, Naik SN, Mirdha BR, Padhi MM, et al. Double-Blinded Randomized Controlled Trial for Immunomodulatory Effects of Tulsi (Ocimum Sanctum Linn.) Leaf Extract on Healthy Volunteers. J Ethnopharmacol (2011) 136:452–6. doi: 10.1016/j.jep.2011.05.012

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Chiang L-C, Ng L-T, Cheng P-W, Chiang W, Lin C-C. Antiviral Activities of Extracts and Selected Pure Constituents of Ocimum Basilicum. Clin Exp Pharmacol Physiol (2005) 32:811–6. doi: 10.1111/j.1440-1681.2005.04270.x

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Hamidpour M, Hamidpour R, Hamidpour S, Shahlari M. Chemistry, Pharmacology, and Medicinal Property of Sage (Salvia) to Prevent and Cure Illnesses Such as Obesity, Diabetes, Depression, Dementia, Lupus, Autism, Heart Disease, and Cancer. J Tradit Complement Med (2014) 4:82–8. doi: 10.4103/2225-4110.130373

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Ghorbani A, Esmaeilizadeh M. Pharmacological Properties of Salvia Officinalis and its Components. J Tradit Complement Med (2017) 7:433–40. doi: 10.1016/j.jtcme.2016.12.014

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Geuenich S, Goffinet C, Venzke S, Nolkemper S, Baumann I, Plinkert P, et al. Aqueous Extracts From Peppermint, Sage and Lemon Balm Leaves Display Potent Anti-HIV-1 Activity by Increasing the Virion Density. Retrovirology (2008) 5:1–16. doi: 10.1186/1742-4690-5-27

PubMed Abstract | CrossRef Full Text | Google Scholar

76. Badgujar SB, Patel VV, Bandivdekar AH. Foeniculum Vulgare Mill: A Review of its Botany, Phytochemistry, Pharmacology, Contemporary Application, and Toxicology. BioMed Res Int (2014) 2014:1–32. doi: 10.1155/2014/842674

CrossRef Full Text | Google Scholar

77. Astani A, Reichling J, Schnitzler P. Screening for Antiviral Activities of Isolated Compounds From Essential Oils. Evidence-Based Complement Altern Med (2011) 2011:1–8. doi: 10.1093/ecam/nep187

CrossRef Full Text | Google Scholar

78. Lee HS, Kang P, Kim KY, Seol GH. Foeniculum Vulgare Mill. Protects Against Lipopolysaccharide-Induced Acute Lung Injury in Mice Through ERK-Dependent NF-kB Activation. Korean J Physiol Pharmacol (2015) 19:183–9. doi: 10.4196/kjpp.2015.19.2.183

PubMed Abstract | CrossRef Full Text | Google Scholar

79. Pourghanbari G, Nili H, Moattari A, Mohammadi A, Iraji A. Antiviral Activity of the Oseltamivir and Melissa Officinalis L. Essential Oil Against Avian Influenza A Virus (H9N2). Virusdisease (2016) 27:170–8. doi: 10.1007/s13337-016-0321-0

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Schnitzler P, Schuhmacher A, Astani A, Reichling J. Melissa Officinalis Oil Affects Infectivity of Enveloped Herpesviruses. Phytomedicine (2008) 15:734–40. doi: 10.1016/j.phymed.2008.04.018

PubMed Abstract | CrossRef Full Text | Google Scholar

81. Astani A, Navid MH, Schnitzler P. Attachment and Penetration of Acyclovir-Resistant Herpes Simplex Virus are Inhibited by Melissa Officinalis Extract. Phytother Res (2014) 28:1547–52. doi: 10.1002/ptr.5166

PubMed Abstract | CrossRef Full Text | Google Scholar

82. Chen S-G, Leu Y-L, Cheng M-L, Ting SC, Liu C-C, Wang S-D, et al. Anti-Enterovirus 71 Activities of Melissa Officinalis Extract and its Biologically Active Constituent Rosmarinic Acid. Sci Rep (2017) 7:12264. doi: 10.1038/s41598-017-12388-2

PubMed Abstract | CrossRef Full Text | Google Scholar

83. Rahman MA, Ueda K, Honda T. A Traditional Chinese Medicine, Maoto, Suppresses Hepatitis B Virus Production. Front Cell Infect Microbiol (2021) 10:581345. doi: 10.3389/fcimb.2020.581345

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Wang L, Yang R, Yuan B, Liu Y, Liu C. The Antiviral and Antimicrobial Activities of Licorice, a Widely-Used Chinese Herb. Acta Pharm Sin B (2015) 5:310–5. doi: 10.1016/j.apsb.2015.05.005

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Yoshino T, Arita R, Horiba Y, Watanabe K. The Use of Maoto (Ma-Huang-Tang), a Traditional Japanese Kampo Medicine, to Alleviate Flu Symptoms: A Systematic Review and Meta-Analysis. BMC Complement Altern Med (2019) 19:68. doi: 10.1186/s12906-019-2474-z

PubMed Abstract | CrossRef Full Text | Google Scholar

86. Feng Yeh C, Chih Wang K, Chai Chiang L, Shieh DE, Hong Yen M, San Chang J. Water Extract of Licorice had Anti-Viral Activity Against Human Respiratory Syncytial Virus in Human Respiratory Tract Cell Lines. J Ethnopharmacol (2013) 148:466–73. doi: 10.1016/j.jep.2013.04.040

PubMed Abstract | CrossRef Full Text | Google Scholar

87. Fukuchi K, Okudaira N, Adachi K, Odai-Ide R, Watanabe S, Ohno H, et al. Antiviral and Antitumor Activity of Licorice Root Extracts. In Vivo (Brooklyn) (2016) 30:777–85. doi: 10.21873/invivo.10994

CrossRef Full Text | Google Scholar

88. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an Active Component of Liquorice Roots, and Replication of SARS-Associated Coronavirus. Lancet (2003) 361:2045–6. doi: 10.1016/S0140-6736(03)13615-X

PubMed Abstract | CrossRef Full Text | Google Scholar

89. Jia Y-Y, Guan R-F, Wu Y-H, Yu X-P, Lin W-Y, Zhang Y-Y, et al. Taraxacum Mongolicum Extract Exhibits a Protective Effect on Hepatocytes and an Antiviral Effect Against Hepatitis B Virus in Animal and Human Cells. Mol Med Rep (2014) 9:1381–7. doi: 10.3892/mmr.2014.1925

PubMed Abstract | CrossRef Full Text | Google Scholar

90. Han H, He W, Wang W, Gao B. Inhibitory Effect of Aqueous Dandelion Extract on HIV-1 Replication and Reverse Transcriptase Activity. BMC Complement Altern Med (2011) 11:1–10. doi: 10.1186/1472-6882-11-112

PubMed Abstract | CrossRef Full Text | Google Scholar

91. He W, Han H, Wang W, Gao B. Anti-Influenza Virus Effect of Aqueous Extracts From Dandelion. Virol J (2011) 8:1–11. doi: 10.1186/1743-422X-8-538

PubMed Abstract | CrossRef Full Text | Google Scholar

92. Meireles D, Gomes J, Lopes L, Hinzmann M, Machado J. A Review of Properties, Nutritional and Pharmaceutical Applications of Moringa Oleifera: Integrative Approach on Conventional and Traditional Asian Medicine. Adv Tradit Med (2020) 20:495–515. doi: 10.1007/s13596-020-00468-0

CrossRef Full Text | Google Scholar

93. Gasmalbari E, Elobeid A, Abbadi O. The Use of Traditional Medicines, Vitamins, and Minerals Against COVID - 19. Int J Recent Res Life Sci (2020) 7:15–24. Available at: https://www.paperpublications.org/issue/IJRRLS/Issue-4-October-2020-December-2020.

Google Scholar

94. Sachdeva V, Roy A, Bharadvaja N. Current Prospects of Nutraceuticals: A Review. Curr Pharm Biotechnol (2020) 21:884–96. doi: 10.2174/1389201021666200130113441

PubMed Abstract | CrossRef Full Text | Google Scholar

95. Kulyar MF-A, Li R, Mehmood K, Waqas M, Li K, Li J. Potential Influence of Nagella Sativa (Black Cumin) in Reinforcing Immune System: A Hope to Decelerate the COVID-19 Pandemic. Phytomedicine (2020) 85:1–8. doi: 10.1016/j.phymed.2020.153277

CrossRef Full Text | Google Scholar

96. Oladele JO, Ajayi EI, Oyeleke OM, Oladele OT, Olowookere BD, Adeniyi BM, et al. A Systematic Review on COVID-19 Pandemic With Special Emphasis on Curative Potentials of Nigeria Based Medicinal Plants. Heliyon (2020) 6:1–17. doi: 10.1016/j.heliyon.2020.e04897

CrossRef Full Text | Google Scholar

97. Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: A Promising Cure for the Global Panic. Sci Total Environ (2020) 725:1–18. doi: 10.1016/j.scitotenv.2020.138277

CrossRef Full Text | Google Scholar

98. Khanna K, Kohli SK, Kaur R, Bhardwaj A, Bhardwaj V, Ohri P, et al. Herbal Immune-Boosters: Substantial Warriors of Pandemic Covid-19 Battle. Phytomedicine (2021) 85:153361. doi: 10.1016/j.phymed.2020.153361

PubMed Abstract | CrossRef Full Text | Google Scholar

99. Panyod S, Ho C-T, Sheen L-Y. Dietary Therapy and Herbal Medicine for COVID-19 Prevention: A Review and Perspective. J Tradit Complement Med (2020) 10:420–7. doi: 10.1016/j.jtcme.2020.05.004

PubMed Abstract | CrossRef Full Text | Google Scholar

100. Liang C, Hui N, Liu Y, Qiao G, Li J, Tian L, et al. Insights Into Forsythia Honeysuckle (Lianhuaqingwen) Capsules: A Chinese Herbal Medicine Repurposed for COVID-19 Pandemic. Phytomed Plus (2021) 1:100027. doi: 10.1016/j.phyplu.2021.100027

CrossRef Full Text | Google Scholar

101. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, Thrusting Coronaviruses Into the Spotlight. Viruses (2019) 11:59. doi: 10.3390/v11010059

CrossRef Full Text | Google Scholar

102. Wang B, Kovalchuk A, Li D, Ilnytskyy Y, Kovalchuk I, Kovalchuk O. In Search of Preventative Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues. Aging (Albany NY) (2020) 12:22425–44. doi: 10.18632/aging.202225

PubMed Abstract | CrossRef Full Text | Google Scholar

103. Chowdhury MA, Shahid MA, Kashem MA. Scope of Natural Plant Extract to Deactivate COVID-19. Eur PM (2020). doi: 10.21203/rs.3.rs-19240/v1

CrossRef Full Text | Google Scholar

104. Meneguzzo F, Ciriminna R, Zabini F, Pagliaro M. Review of Evidence Available on Hesperidin-Rich Products as Potential Tools Against COVID-19 and Hydrodynamic Cavitation-Based Extraction as a Method of Increasing Their Production. Processes (2020) 8:549. doi: 10.3390/pr8050549

CrossRef Full Text | Google Scholar

105. Nagle V, Gaikwad M, Pawar Y, Dasgupta S. Marine Red Alga Porphyridium Sp. As a Source of Sulfated Polysaccharides (SPs) for Combating Against COVID-19. Preprints (2020) 2020040168.

Google Scholar

106. Walter TM, Justinraj CS, Nandini VS. Effect of Nilavembu Kudineer in the Prevention and Management of COVID–19 by Inhibiting ACE2 Receptor. Siddha Papers (2020) 15(2):531–5.

Google Scholar

107. Salim B, Noureddine M. Identification of Compounds From Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus (Covid-19): Molecular Docking Study. ChemRxiv (2020), 2020040079. doi: 10.20944/preprints202004.0079.v1

CrossRef Full Text | Google Scholar

108. Bhatia S, Giri S, Lal AF, Singh S. Battle Against Coronavirus: Repurposing Old Friends (Food Borne Polyphenols) for New Enemy (COVID-19). ChemRxiv (2020). doi: 10.26434/chemrxiv.12108546

CrossRef Full Text | Google Scholar

109. Rathinavel T, Palanisamy M, Palanisamy S, Subramanian A, Thangaswamy S. Phytochemical 6-Gingerol – A Promising Drug of Choice for COVID-19. Int J Adv Sci Eng (2020) 06:1482–9. doi: 10.29294/ijase.6.4.2020.1482-1489

CrossRef Full Text | Google Scholar

110. Adem S, Eyupoglu V, Sarfraz I, Rasul A, Ali M. Identification of Potent COVID-19 Main Protease (Mpro) Inhibitors From Natural Polyphenols: An in Silico Strategy Unveils a Hope Against CORONA. Preprints (2020). doi: 10.20944/preprints202003.0333.v1

CrossRef Full Text | Google Scholar

111. Thuy BTP, My TTA, Hai NTT, Hieu LT, Hoa TT, Thi Phuong Loan H, et al. Investigation Into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil. ACS Omega (2020) 5:8312–20. doi: 10.1021/acsomega.0c00772

PubMed Abstract | CrossRef Full Text | Google Scholar

112. Shaghaghi N. Molecular Docking Study of Novel COVID-19 Protease With Low Risk Terpenoides Compounds of Plants. ChemRxiv (2020). doi: 10.26434/chemrxiv.11935722

CrossRef Full Text | Google Scholar

113. Khan S, Siddique R, Li H, Ali A, Shereen MA, Bashir N, et al. Impact of Coronavirus Outbreak on Psychological Health. J Glob Health (2020) 10:1–6. doi: 10.7189/JOGH.10.010331

CrossRef Full Text | Google Scholar

114. Sharma AD, Kaur I. Jensenone From Eucalyptus Essential Oil as a Potential Inhibitor of COVID 19 Corona Virus Infection. Res Rev Biotechnol Biosci (2020) 7:59–66. doi: 10.5281/zenodo.3748477

CrossRef Full Text | Google Scholar

115. Khairan K, Idroes R, Tallei TE, Nasim MJ, Jacob C. Bioactive Compounds From Medicinal Plants and Their Possible Effect as Therapeutic Agents Against COVID-19: A Review. Curr Nutr Food Sci (2021) 17:621–33. doi: 10.2174/1573401317999210112201439

CrossRef Full Text | Google Scholar

116. Shah K, Kamrai D, Mekala H, Mann B, Desai K, Patel RS. Focus on Mental Health During the Coronavirus (COVID-19) Pandemic: Applying Learnings From the Past Outbreaks. Cureus (2020) 12:1–6. doi: 10.7759/cureus.7405

CrossRef Full Text | Google Scholar

117. Jovic TH, Ali SR, Ibrahim N, Jessop ZM, Tarassoli SP, Dobbs TD, et al. Could Vitamins Help in the Fight Against Covid-19? Nutrients (2020) 12:1–30. doi: 10.3390/nu12092550

CrossRef Full Text | Google Scholar

118. National Research Council. Recommended Dietary Allowances. Washington, D.C: National Academies Press (1989). doi: 10.17226/1349

CrossRef Full Text | Google Scholar

119. Toledano JM, Moreno-Fernandez J, Puche-Juarez M, Ochoa JJ, Diaz-Castro J. Implications of Vitamins in COVID-19 Prevention and Treatment Through Immunomodulatory and Anti-Oxidative Mechanisms. Antioxidants (2021) 11:5. doi: 10.3390/antiox11010005

PubMed Abstract | CrossRef Full Text | Google Scholar

120. Tepasse P-R, Vollenberg R, Fobker M, Kabar I, Schmidt H, Meier JA, et al. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients (2021) 13:2173. doi: 10.3390/nu13072173

PubMed Abstract | CrossRef Full Text | Google Scholar

121. Sharma L. Dietary Management to Build Adaptive Immunity Against COVID19. J PeerSci (2020) 2:1–6. doi: 10.9790/3008-1503032229

CrossRef Full Text | Google Scholar

122. Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients (2017) 9:1–25. doi: 10.3390/nu9111211

CrossRef Full Text | Google Scholar

123. Khan MF, Khan MA, Khan ZA, Ahamad T, Ansari WA. Identification of Dietary Molecules as Therapeutic Agents to Combat COVID-19 Using Molecular Docking Studies. preprints (2020). doi: 10.21203/rs.3.rs-19560/v1

CrossRef Full Text | Google Scholar

124. Hemilä H, de Man AME. Vitamin C and COVID-19. Front Med (2021) 7:559811. doi: 10.3389/fmed.2020.559811

CrossRef Full Text | Google Scholar

125. Name JJ, Souza ACR, Vasconcelos AR, Prado PS, Pereira CPM. Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity. Front Nutr (2020) 7:606398. doi: 10.3389/fnut.2020.606398

PubMed Abstract | CrossRef Full Text | Google Scholar

126. Uddin MS, Millat MS, Baral PK, Ferdous M, Uddin MG, Sarwar MS, et al. The Protective Role of Vitamin C in the Management of COVID-19: A Review. J Egypt Public Health Assoc (2021) 96:33. doi: 10.1186/s42506-021-00095-w

PubMed Abstract | CrossRef Full Text | Google Scholar

127. Bendich A, Machlin LJ, Scandurra O, Burton GW, Wayner DDM. The Antioxidant Role of Vitamin C. Adv Free Radic Biol Med (1986) 2:419–44. doi: 10.1016/S8755-9668(86)80021-7

CrossRef Full Text | Google Scholar

128. Hemila H. Vitamin C. And SARS Coronavirus. J Antimicrob Chemother (2003) 52:1049–50. doi: 10.1093/jac/dkh002

PubMed Abstract | CrossRef Full Text | Google Scholar

129. Atherton JG, Kratzing CC, Fisher A. The Effect of Ascorbic Acid on Infection Chick-Embryo Ciliated Tracheal Organ Cultures by Coronavirus. Arch Virol (1978) 56:195–9. doi: 10.1007/BF01317848

PubMed Abstract | CrossRef Full Text | Google Scholar

130. Field CJ, Johnson IR, Schley PD. Nutrients and Their Role in Host Resistance to Infection. J Leukoc Biol (2002) 71:16–32. doi: 10.1189/jlb.71.1.16

PubMed Abstract | CrossRef Full Text | Google Scholar

131. Teafatiller T, Agrawal S, De Robles G, Rahmatpanah F, Subramanian VS, Agrawal A. Vitamin C Enhances Antiviral Functions of Lung Epithelial Cells. Biomolecules (2021) 11:1148. doi: 10.3390/biom11081148

PubMed Abstract | CrossRef Full Text | Google Scholar

132. Holick MF. Sunlight and Vitamin D for Bone Health and Prevention of Autoimmune Diseases, Cancers, and Cardiovascular Disease. Am J Clin Nutr (2004) 80:1678S–88S. doi: 10.1093/ajcn/80.6.1678S

PubMed Abstract | CrossRef Full Text | Google Scholar

133. Holick MF. High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clin Proc (2006) 81:353–73. doi: 10.4065/81.3.353

PubMed Abstract | CrossRef Full Text | Google Scholar

134. Beard JA, Bearden A, Striker R. Vitamin D and the Anti-Viral State. J Clin Virol (2011) 50:194–200. doi: 10.1016/j.jcv.2010.12.006

PubMed Abstract | CrossRef Full Text | Google Scholar

135. Luong K, Nguyen LTH. Impact of Vitamin D in the Treatment of Tuberculosis. Am J Med Sci (2011) 341:493–8. doi: 10.1097/MAJ.0b013e3182070f47

PubMed Abstract | CrossRef Full Text | Google Scholar

136. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ (2017) 356:i6583. doi: 10.1136/bmj.i6583

PubMed Abstract | CrossRef Full Text | Google Scholar

137. Bauer SR, Kapoor A, Rath M, Thomas SA. What Is the Role of Supplementation With Ascorbic Acid, Zinc, Vitamin D, or N -Acetylcysteine for Prevention or Treatment of COVID-19? Cleve Clin J Med (2020), 1–3. doi: 10.3949/ccjm.87a.ccc046

CrossRef Full Text | Google Scholar

138. Linneberg A, Kampmann FB, Israelsen SB, Andersen LR, Jørgensen HL, Sandholt H, et al. The Association of Low Vitamin K Status With Mortality in a Cohort of 138 Hospitalized Patients With COVID-19. Nutrients (2021) 13:1985. doi: 10.3390/nu13061985

PubMed Abstract | CrossRef Full Text | Google Scholar

139. Janssen R, Visser MPJ, Dofferhoff ASM, Vermeer C, Janssens W, Walk J. Vitamin K Metabolism as the Potential Missing Link Between Lung Damage and Thromboembolism in Coronavirus Disease 2019. Br J Nutr (2020) 126:191–8. doi: 10.1017/S0007114520003979

PubMed Abstract | CrossRef Full Text | Google Scholar

140. Melhus H. Excessive Dietary Intake of Vitamin A Is Associated With Reduced Bone Mineral Density and Increased Risk for Hip Fracture. Ann Intern Med (1998) 129:770. doi: 10.7326/0003-4819-129-10-199811150-00003

PubMed Abstract | CrossRef Full Text | Google Scholar

141. Slatore CG, Littman AJ, Au DH, Satia JA, White E. Long-Term Use of Supplemental Multivitamins, Vitamin C, Vitamin E, and Folate Does Not Reduce the Risk of Lung Cancer. Am J Respir Crit Care Med (2008) 177:524–30. doi: 10.1164/rccm.200709-1398OC

PubMed Abstract | CrossRef Full Text | Google Scholar

142. Ebbing M. Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12. JAMA (2009) 302:2119. doi: 10.1001/jama.2009.1622

PubMed Abstract | CrossRef Full Text | Google Scholar

143. Kesse-Guyot E, Bertrais S, Duperray B, Arnault N, Bar-Hen A, Galan P, et al. Dairy Products, Calcium and the Risk of Breast Cancer: Results of the French SU.VI.MAX Prospective Study. Ann Nutr Metab (2007) 51:139–45. doi: 10.1159/000103274

PubMed Abstract | CrossRef Full Text | Google Scholar

144. McCullough ML. Dairy, Calcium, and Vitamin D Intake and Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomark Prev (2005) 14:2898–904. doi: 10.1158/1055-9965.EPI-05-0611

CrossRef Full Text | Google Scholar

145. Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, et al. Hydroxychloroquine, a Less Toxic Derivative of Chloroquine, Is Effective in Inhibiting SARS-CoV-2 Infection in vitro. Cell Discov (2020) 6:16. doi: 10.1038/s41421-020-0156-0

PubMed Abstract | CrossRef Full Text | Google Scholar

146. Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. New Insights Into the Antiviral Effects of Chloroquine. Lancet Infect Dis (2006) 6:67–9. doi: 10.1016/S1473-3099(06)70361-9

PubMed Abstract | CrossRef Full Text | Google Scholar

147. Dong L, Hu S, Gao J. Discovering Drugs to Treat Coronavirus Disease 2019 (COVID-19). Drug Discov Ther (2020) 14:58–60. doi: 10.5582/ddt.2020.01012

PubMed Abstract | CrossRef Full Text | Google Scholar

148. Hendaus MA. Remdesivir in the Treatment of Coronavirus Disease 2019 (COVID-19): A Simplified Summary. J Biomol Struct Dyn (2021) 39:3787–92. doi: 10.1080/07391102.2020.1767691

PubMed Abstract | CrossRef Full Text | Google Scholar

149. Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, et al. COVID-19: Combining Antiviral and Anti-Inflammatory Treatments. Lancet Infect Dis (2020) 20:400–2. doi: 10.1016/S1473-3099(20)30132-8

PubMed Abstract | CrossRef Full Text | Google Scholar

150. Choy K-T, Wong AY-L, Kaewpreedee P, Sia SF, Chen D, Hui KPY, et al. Remdesivir, Lopinavir, Emetine, and Homoharringtonine Inhibit SARS-CoV-2 Replication In Vitro. Antiviral Res (2020) 178:104786. doi: 10.1016/j.antiviral.2020.104786

PubMed Abstract | CrossRef Full Text | Google Scholar

151. Venisse N, Peytavin G, Bouchet S, Gagnieu M-C, Garraffo R, Guilhaumou R, et al. Concerns About Pharmacokinetic (PK) and Pharmacokinetic-Pharmacodynamic (PK-PD) Studies in the New Therapeutic Area of COVID-19 Infection. Antiviral Res (2020) 181:104866. doi: 10.1016/j.antiviral.2020.104866

PubMed Abstract | CrossRef Full Text | Google Scholar

152. Acquavia MA, Foti L, Pascale R, Nicolò A, Brancaleone V, Cataldi TRI, et al. Detection and Quantification of Covid-19 Antiviral Drugs in Biological Fluids and Tissues. Talanta (2021) 224:121862. doi: 10.1016/j.talanta.2020.121862

PubMed Abstract | CrossRef Full Text | Google Scholar

153. Khadka S, Yuchi A, Shrestha DB, Budhathoki P, Al-Subari SMM, Ziad Alhouzani TM, et al. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic. Altern Ther Health Med (2020) 26:100–7.

PubMed Abstract | Google Scholar

154. Parvathaneni V, Gupta V. Utilizing Drug Repurposing Against COVID-19 – Efficacy, Limitations, and Challenges. Life Sci (2020) 259:118275. doi: 10.1016/j.lfs.2020.118275

PubMed Abstract | CrossRef Full Text | Google Scholar

155. Demeke CA, Woldeyohanins AE, Kifle ZD. Herbal Medicine Use for the Management of COVID-19: A Review Article. Metab Open (2021) 12:100141. doi: 10.1016/j.metop.2021.100141

CrossRef Full Text | Google Scholar

156. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). JAMA (2020) 323:1824–36. doi: 10.1001/jama.2020.6019

PubMed Abstract | CrossRef Full Text | Google Scholar

157. Gbinigie K, Frie K. Should Chloroquine and Hydroxychloroquine be Used to Treat COVID-19? A Rapid Review. BJGP Open (2020) 4:bjgpopen20X101069. doi: 10.3399/bjgpopen20X101069

PubMed Abstract | CrossRef Full Text | Google Scholar

158. Low ZY, Farouk IA, Lal SK. Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak. Viruses (2020) 12:1058. doi: 10.3390/v12091058

CrossRef Full Text | Google Scholar

159. Barlow A, Landolf KM, Barlow B, Yeung SYA, Heavner JJ, Claassen CW, et al. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. Pharmacother J Hum Pharmacol Drug Ther (2020) 40:416–37. doi: 10.1002/phar.2398

CrossRef Full Text | Google Scholar

160. Yasui H, Shida K, Matsuzaki T, Yokokura T. Immunomodulatory Function of Lactic Acid Bacteria. Antonie Van Leeuwenhoek. Int J Gen Mol Microbiol (1999) 76:383–9. doi: 10.1023/A:1002041616085

CrossRef Full Text | Google Scholar

161. Hori T, Kivoshima J, Shida K, Yasui H. Augmentation of Cellular Immunity and Reduction of Influenza Virus Titer in Aged Mice Fed Lactobacillus Casei Strain Shirota. Clin Diagn Lab Immunol (2002) 9:105–8. doi: 10.1128/CDLI.9.1.105-108.2002

PubMed Abstract | CrossRef Full Text | Google Scholar

162. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, et al. Effect of Long Term Consumption of Probiotic Milk on Infections in Children Attending Day Care Centres: Double Blind, Randomised Trial. Br Med J (2001) 322:1327–9. doi: 10.1136/bmj.322.7298.1327

CrossRef Full Text | Google Scholar

163. Hossain KS, Hossain MG, Moni A, Rahman MM, Rahman UH, Alam M, et al. Prospects of Honey in Fighting Against COVID-19: Pharmacological Insights and Therapeutic Promises. Heliyon (2020) 6:e05798. doi: 10.1016/j.heliyon.2020.e05798

PubMed Abstract | CrossRef Full Text | Google Scholar

164. Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 Immunity: Review and Applications to Phase 3 Vaccine Candidates. Lancet (2020) 396:1595–606. doi: 10.1016/S0140-6736(20)32137-1

PubMed Abstract | CrossRef Full Text | Google Scholar

165. Ball DW. The Chemical Composition of Honey. J Chem Educ (2007) 84:1643–6. doi: 10.1021/ED084P1643

CrossRef Full Text | Google Scholar

166. Cheng N, Wang Y, Cao W. The Protective Effect of Whole Honey and Phenolic Extract on Oxidative DNA Damage in Mice Lymphocytes Using Comet Assay. Plant Foods Hum Nutr (2017) 72:388–95. doi: 10.1007/S11130-017-0634-1

PubMed Abstract | CrossRef Full Text | Google Scholar

167. Dżugan M, Sowa P, Kwaśniewska M, Wesołowska M, Czernicka M. Physicochemical Parameters and Antioxidant Activity of Bee Honey Enriched With Herbs. Plant Foods Hum Nutr (2017) 72:74–81. doi: 10.1007/s11130-016-0593-y

PubMed Abstract | CrossRef Full Text | Google Scholar

168. Sulaiman SA, Hasan H, Deris Z, Wahad MS, Yousof RC, Naing N, et al. The Benefit of Tualang Honey in Reducing Acute Respiratory Symptoms Among Malaysian Hajj Pilgrims: A Preliminary Study. J Apiproduct Apimed Sci (2011) 3:38–44. doi: 10.3896/IBRA.4.03.1.07

CrossRef Full Text | Google Scholar

169. Wessels I, Rolles B, Rink L. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis. Front Immunol (2020) 11:1712. doi: 10.3389/fimmu.2020.01712

PubMed Abstract | CrossRef Full Text | Google Scholar

170. Jothimani D, Kailasam E, Danielraj S, Nallathambi B, Ramachandran H, Sekar P, et al. COVID-19: Poor Outcomes in Patients With Zinc Deficiency. Int J Infect Dis (2020) 100:343–9. doi: 10.1016/j.ijid.2020.09.014

PubMed Abstract | CrossRef Full Text | Google Scholar

171. Maywald M, Wessels I, Rink L. Zinc Signals and Immunity. Int J Mol Sci (2017) 18:2222. doi: 10.3390/ijms18102222

CrossRef Full Text | Google Scholar

172. Bouvet M, Debarnot C, Imbert I, Selisko B, Snijder EJ, Canard B, et al. In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation. PloS Pathog (2010) 6:e1000863. doi: 10.1371/journal.ppat.1000863

PubMed Abstract | CrossRef Full Text | Google Scholar

173. Asl SH, Nikfarjam S, Majidi Zolbanin N, Nassiri R, Jafari R. Immunopharmacological Perspective on Zinc in SARS-CoV-2 Infection. Int Immunopharmacol (2021) 96:107630. doi: 10.1016/j.intimp.2021.107630

PubMed Abstract | CrossRef Full Text | Google Scholar

174. Vogel-González M, Talló-Parra M, Herrera-Fernández V, Pérez-Vilaró G, Chillón M, Nogués X, et al. Low Zinc Levels at Admission Associates With Poor Clinical Outcomes in SARS-CoV-2 Infection. Nutrients (2021) 13:562. doi: 10.3390/nu13020562

PubMed Abstract | CrossRef Full Text | Google Scholar

175. Razzaque MS. COVID-19 Pandemic: Can Zinc Supplementation Provide an Additional Shield Against the Infection? Comput Struct Biotechnol J (2021) 19:1371–8. doi: 10.1016/j.csbj.2021.02.015

PubMed Abstract | CrossRef Full Text | Google Scholar

176. Quilliot D, Bonsack O, Jaussaud R, Mazur A. Dysmagnesemia in Covid-19 Cohort Patients: Prevalence and Associated Factors. Magnes Res (2020) 33:114–22. doi: 10.1684/mrh.2021.0476

PubMed Abstract | CrossRef Full Text | Google Scholar

177. Tang C-F, Ding H, Jiao R-Q, Wu X-X, Kong L-D. Possibility of Magnesium Supplementation for Supportive Treatment in Patients With COVID-19. Eur J Pharmacol (2020) 886:173546. doi: 10.1016/j.ejphar.2020.173546

PubMed Abstract | CrossRef Full Text | Google Scholar

178. Dominguez LJ, Veronese N, Guerrero-Romero F, Barbagallo M. Magnesium in Infectious Diseases in Older People. Nutrients (2021) 13:180. doi: 10.3390/nu13010180

CrossRef Full Text | Google Scholar

179. Uwitonze AM. Razzaque MS.Role of Magnesium in Vitamin D Activation Andfunction. J Am Osteopath Assoc (2018) 118:181–9. doi: 10.7556/jaoa.2018.037

PubMed Abstract | CrossRef Full Text | Google Scholar

180. Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, et al. A Cohort Study to Evaluate the Effect of Combination Vitamin D, Magnesium and Vitamin B12 on Progression to Severe Outcome in Older COVID-19 Patients. Nutrition (2020) 79-80:111017. doi: 10.1016/j.nut.2020.111017

PubMed Abstract | CrossRef Full Text | Google Scholar

181. DiNicolantonio JJ, O’Keefe JH. Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in Covid-19 Patients. Mo Med (2021) 118:68–73.

PubMed Abstract | Google Scholar

182. Maggini S, Pierre A, Calder P. Immune Function and Micronutrient Requirements Change Over the Life Course. Nutrients (2018) 10:1531. doi: 10.3390/nu10101531

CrossRef Full Text | Google Scholar

183. Percival SS. Copper and Immunity. Am J Clin Nutr (1998) 67:1064S–8S. doi: 10.1093/ajcn/67.5.1064S

PubMed Abstract | CrossRef Full Text | Google Scholar

184. Besold AN, Culbertson EM, Culotta VC. The Yin and Yang of Copper During Infection. JBIC J Biol Inorg Chem (2016) 21:137–44. doi: 10.1007/s00775-016-1335-1

CrossRef Full Text | Google Scholar

185. Warnes SL, Little ZR, Keevil CW. Human Coronavirus 229e Remains Infectious on Common Touch Surface Materials. MBio (2015) 6:1–15. doi: 10.1128/mBio.01697-15

CrossRef Full Text | Google Scholar

186. Mao S, Zhang A, Huang S. Meta-Analysis of Zn, Cu and Fe in the Hair of Chinese Children With Recurrent Respiratory Tract Infection. Scand J Clin Lab Invest (2014) 74:561–7. doi: 10.3109/00365513.2014.921323

PubMed Abstract | CrossRef Full Text | Google Scholar

187. Huang Z, Rose AH, Hoffmann PR. The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities. AntioxidRedox Signal (2012) 16:705–43. doi: 10.1089/ars.2011.4145

CrossRef Full Text | Google Scholar

188. Arthur JR, McKenzie RC, Beckett GJ. Selenium in the Immune System. J Nutr (2003) 133:1457S–9S. doi: 10.1093/jn/133.5.1457S

PubMed Abstract | CrossRef Full Text | Google Scholar

189. McKenzie RC S, Rafferty T, Beckett GJ. Selenium: An Essential Element for Immune Function. Immunol Today (1998) 19:342–5. doi: 10.1016/S0167-5699(98)01294-8

PubMed Abstract | CrossRef Full Text | Google Scholar

190. Peretz A, Nève J, Desmedt J, Duchateau J, Dramaix M, Famaey JP. Lymphocyte Response Is Enhanced by Supplementation of Elderly Subjects With Selenium-Enriched Yeast. Am J Clin Nutr (1991) 53:1323–8. doi: 10.1093/ajcn/53.5.1323

PubMed Abstract | CrossRef Full Text | Google Scholar

191. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Supplementation With Selenium and Human Immune Cell Functions: I. Effect on Lymphocyte Proliferation and Interleukin 2 Receptor Expression. Biol Trace Elem Res (1994) 46:183–3. doi: 10.1007/BF02790078

CrossRef Full Text | Google Scholar

192. Auinger A, Riede L, Bothe G, Busch R, Gruenwald J. Yeast (1,3)-(1,6)-Beta-Glucan Helps to Maintain the Body’s Defence Against Pathogens: A Double-Blind, Randomized, Placebo-Controlled, Multicentric Study in Healthy Subjects. Eur J Nutr (2013) 52:1913–8. doi: 10.1007/s00394-013-0492-z

PubMed Abstract | CrossRef Full Text | Google Scholar

193. Graubaum H-J, Busch R, Stier H, Gruenwald J. A Double-Blind, Randomized, Placebo-Controlled Nutritional Study Using an Insoluble Yeast Beta-Glucan to Improve the Immune Defense System. Food Nutr Sci (2012) 03:738–46. doi: 10.4236/fns.2012.36100

CrossRef Full Text | Google Scholar

194. McFarlin BK, Carpenter KC, Davidson T, McFarlin MA. Baker’s Yeast Beta Glucan Supplementation Increases Salivary IgA and Decreases Cold/Flu Symptomatic Days After Intense Exercise. J Diet Suppl (2013) 10:171–83. doi: 10.3109/19390211.2013.820248

PubMed Abstract | CrossRef Full Text | Google Scholar

195. Mahn A, Castillo A. Potential of Sulforaphane as a Natural Immune System Enhancer: A Review. Molecules (2021) 26:752. doi: 10.3390/molecules26030752

PubMed Abstract | CrossRef Full Text | Google Scholar

196. Thota SM, Balan V, Sivaramakrishnan V. Natural Products as Home-Based Prophylactic and Symptom Management Agents in the Setting of COVID -19. Phyther Res (2020) 34:3148–67. doi: 10.1002/ptr.6794

CrossRef Full Text | Google Scholar

197. Levy M, Thaiss CA, Elinav E. Metabolites: Messengers Between the Microbiota and the Immune System. Genes Dev (2016) 30:1589–97. doi: 10.1101/gad.284091.116

PubMed Abstract | CrossRef Full Text | Google Scholar

198. Bartolini D, Stabile AM, Bastianelli S, Giustarini D, Pierucci S, Busti C, et al. SARS-CoV2 Infection Impairs the Metabolism and Redox Function of Cellular Glutathione. Redox Biol (2021) 45:102041. doi: 10.1016/j.redox.2021.102041

PubMed Abstract | CrossRef Full Text | Google Scholar

199. Thaker SK, Chng J, Christofk HR. Viral hijacking of cellular metabolism. BMC Biol (2019) 17:1–15. doi: 10.1186/s12915-019-0678-9

PubMed Abstract | CrossRef Full Text | Google Scholar

200. Venegas DP, de la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, et al. Short Chain Fatty Acids (SCFAs)mediated Gut Epithelial and Immune Regulation and its Relevance for Inflammatory Bowel Diseases. Front Immunol (2019) 10:277. doi: 10.3389/fimmu.2019.00277

PubMed Abstract | CrossRef Full Text | Google Scholar

201. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The Role of Short-Chain Fatty Acids in the Interplay Between Diet, Gut Microbiota, and Host Energy Metabolism. J Lipid Res (2013) 54:2325–40. doi: 10.1194/jlr.R036012

PubMed Abstract | CrossRef Full Text | Google Scholar

202. Hubbard TD, Murray IA, Perdew GH. Special Section on Drug Metabolism and the Microbiome - Minireview Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation. Drug Metab Dispos (2015) 43:1522–35. doi: 10.1124/dmd.115.064246

PubMed Abstract | CrossRef Full Text | Google Scholar

203. Qiu J, Guo X, Chen ZE, He L, Sonnenberg GF, Artis D, et al. Group 3 Innate Lymphoid Cells Inhibit T-Cell-Mediated Intestinal Inflammation Through Aryl Hydrocarbon Receptor Signaling and Regulation of Microflora. Immunity (2013) 39:386–99. doi: 10.1016/j.immuni.2013.08.002

PubMed Abstract | CrossRef Full Text | Google Scholar

204. Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF, et al. Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation. Cell (2011) 147:629–40. doi: 10.1016/j.cell.2011.09.025

PubMed Abstract | CrossRef Full Text | Google Scholar

205. Balić A, Vlašić D, Žužul K, Marinović B, Bukvić Mokos Z. Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases. Int J Mol Sci (2020) 21:741. doi: 10.3390/ijms21030741

CrossRef Full Text | Google Scholar

206. Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, et al. The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza. Cell (2013) 153:112–25. doi: 10.1016/j.cell.2013.02.027

PubMed Abstract | CrossRef Full Text | Google Scholar

207. Lao X, Liu M, Chen J, Zheng H. A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1. PloS One (2013) 8:e72242. doi: 10.1371/journal.pone.0072242

PubMed Abstract | CrossRef Full Text | Google Scholar

208. Li J, Liu CH, Wang FS. Thymosin Alpha 1: Biological Activities, Applications and Genetic Engineering Production. Peptides (2010) 31:2151–8. doi: 10.1016/j.peptides.2010.07.026

PubMed Abstract | CrossRef Full Text | Google Scholar

209. Matteucci C, Minutolo A, Balestrieri E, Petrone V, Fanelli M, Malagnino V, et al. Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients. Open Forum Infect Dis (2021) 8. doi: 10.1093/ofid/ofaa588

PubMed Abstract | CrossRef Full Text | Google Scholar

210. Goldstein G, Audhya TK. Thymopoietin to Thymopentin: Experimental Studies. Surv Immunol Res (1985) 4:1. doi: 10.1007/BF02919050

PubMed Abstract | CrossRef Full Text | Google Scholar

211. Tan Y, Wang W, Wu C, Pan Z, Yao G, Fang L, et al. Myristic Acid-Modified Thymopentin for Enhanced Plasma Stability and Immune-Modulating Activity. Int Immunopharmacol (2017) 47:88–94. doi: 10.1016/j.intimp.2017.03.025

PubMed Abstract | CrossRef Full Text | Google Scholar

212. Joffe MI, Sukha NR, Rabson AR. Lymphocyte Subsets in Measles. Depressed Helper/Inducer Subpopulation Reversed by In Vitro Treatment With Levamisole and Ascorbic Acid. J Clin Invest (1983) 72:971–80. doi: 10.1172/JCI111069

PubMed Abstract | CrossRef Full Text | Google Scholar

213. Devaux CA, Melenotte C, Piercecchi-Marti M-D, Delteil C, Raoult D. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? Front Med (2021) 8:663708. doi: 10.3389/fmed.2021.663708

CrossRef Full Text | Google Scholar

214. de Wilde AH, Zevenhoven-Dobbe JC, van der Meer Y, Thiel V, Narayanan K, Makino S, et al. Cyclosporin A Inhibits the Replication of Diverse Coronaviruses. J Gen Virol (2011) 92:2542–8. doi: 10.1099/vir.0.034983-0

PubMed Abstract | CrossRef Full Text | Google Scholar

215. Bermon S, Castell LM, Calder PC, Bishop NC, Blomstrand E, Mooren FC, et al. Consensus Statement Immunonutrition and Exercise. Exercise Immunol Rev (2017) 23:8–50.

Google Scholar

216. Wedell-Neergaard A-S, Lang Lehrskov L, Christensen RH, Legaard GE, Dorph E, Larsen MK, et al. Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial. Cell Metab (2019) 29:844–55.e3. doi: 10.1016/j.cmet.2018.12.007

PubMed Abstract | CrossRef Full Text | Google Scholar

217. Laddu DR, Lavie CJ, Phillips SA, Arena R. Physical Activity for Immunity Protection: Inoculating Populations With Healthy Living Medicine in Preparation for the Next Pandemic. Prog Cardiovasc Dis (2020) 64:102–4. doi: 10.1016/j.pcad.2020.04.006

PubMed Abstract | CrossRef Full Text | Google Scholar

218. Duggal NA, Niemiro G, Harridge SDR, Simpson RJ, Lord JM. Can Physical Activity Ameliorate Immunosenescence and Thereby Reduce Age-Related Multi-Morbidity? Nat Rev Immunol (2019) 19:563–72. doi: 10.1038/s41577-019-0177-9

PubMed Abstract | CrossRef Full Text | Google Scholar

219. Martin SA, Pence BD, Woods JA. Exercise and Respiratory Tract Viral Infections. Exerc Sport Sci Rev (2009) 37:157–64. doi: 10.1097/JES.0b013e3181b7b57b

PubMed Abstract | CrossRef Full Text | Google Scholar

220. WHO Guidelines on Physical Activity and Sedentary Behaviour. Geneva:World Health Organization (2020) Licence: CC BY-NC-SA 3.0 IGO.

Google Scholar

221. Irwin MR, Opp MR. Sleep Health: Reciprocal Regulation of Sleep and Innate Immunity. Neuropsychopharmacology (2017) 42:129–55. doi: 10.1038/npp.2016.148

PubMed Abstract | CrossRef Full Text | Google Scholar

222. Chaput J-P, Dutil C, Sampasa-Kanyinga H. Sleeping Hours: What is the Ideal Number and How Does Age Impact This? Nat Sci Sleep (2018) 10:421–30. doi: 10.2147/NSS.S163071

PubMed Abstract | CrossRef Full Text | Google Scholar

223. Cohen S. Psychosocial Vulnerabilities to Upper Respiratory Infectious Illness: Implications for Susceptibility to Coronavirus Disease 2019 (COVID-19). Perspect Psychol Sci (2021) 16:161–74. doi: 10.1177/1745691620942516

PubMed Abstract | CrossRef Full Text | Google Scholar

224. Alirezaei M, Kemball CC, Flynn CT, Wood MR, Whitton JL, Kiosses WB. Short-Term Fasting Induces Profound Neuronal Autophagy. Autophagy (2010) 6:702–10. doi: 10.4161/auto.6.6.12376

PubMed Abstract | CrossRef Full Text | Google Scholar

225. Bagherniya M, Butler AE, Barreto GE, Sahebkar A. The Effect of Fasting or Calorie Restriction on Autophagy Induction: A Review of the Literature. Ageing Res Rev (2018) 47:183–97. doi: 10.1016/j.arr.2018.08.004

PubMed Abstract | CrossRef Full Text | Google Scholar

226. Faris “Mo’ez Al-Islam” E, Kacimi S, Al-Kurd RA, Fararjeh MA, Bustanji YK, Mohammad MK, et al. Intermittent Fasting During Ramadan Attenuates Proinflammatory Cytokines and Immune Cells in Healthy Subjects. Nutr Res (2012) 32:947–55. doi: 10.1016/j.nutres.2012.06.021

PubMed Abstract | CrossRef Full Text | Google Scholar

227. Romero M del M, Fernández-López J, Esteve M, Alemany M. Different Modulation by Dietary Restriction of Adipokine Expression in White Adipose Tissue Sites in the Rat. Cardiovasc Diabetol (2009) 8:42. doi: 10.1186/1475-2840-8-42

PubMed Abstract | CrossRef Full Text | Google Scholar

228. Mousa HAL. Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies. J Evid Based Complement Altern Med (2017) 22:166–74. doi: 10.1177/2156587216641831

CrossRef Full Text | Google Scholar

229. Gawade AE, Bale SR. A Nutritional Intervention Against Covid-19: Possibilities on the Use of an Alkaline Diet to Boost Physiological Resistance and Immunity. Indian J Tradit Knowl (2020) 19:S158–63.

Google Scholar

230. Taneja MK. Modified Bhramari Pranayama in Covid 19 Infection. Indian J Otolaryngol Head Neck Surg (2020) 72:395–7. doi: 10.1007/s12070-020-01883-0

PubMed Abstract | CrossRef Full Text | Google Scholar

231. Tyagi SC, Singh M. Multi-Organ Damage by Covid-19: Congestive (Cardio-Pulmonary) Heart Failure, and Blood-Heart Barrier Leakage. Mol Cell Biochem (2021) 476:1891–5. doi: 10.1007/s11010-021-04054-z

PubMed Abstract | CrossRef Full Text | Google Scholar

232. Torales J, O’Higgins M, Castaldelli-Maia JM, Ventriglio A. The Outbreak of COVID-19 Coronavirus and its Impact on Global Mental Health. Int J Soc Psychiatry (2020) 66:317–20. doi: 10.1177/0020764020915212

PubMed Abstract | CrossRef Full Text | Google Scholar

233. Ji D, Ji YJ, Duan XZ, Li WG, Sun ZQ, Song XA, et al. Prevalence of Psychological Symptoms Among Ebola Survivors and Healthcare Workers During the 2014-2015 Ebola Outbreak in Sierra Leone: A Cross-Sectional Study. Oncotarget (2017) 8:12784–91. doi: 10.18632/oncotarget.14498

PubMed Abstract | CrossRef Full Text | Google Scholar

234. Mohindra R, Ravki R, Suri V, Bhalla A, Singh SM. Issues Relevant to Mental Health Promotion in Frontline Health Care Providers Managing Quarantined/Isolated COVID19 Patients. Asian J Psychiatr (2020) 51:102084. doi: 10.1016/j.ajp.2020.102084

PubMed Abstract | CrossRef Full Text | Google Scholar

235. Xiao H, Zhang Y, Kong D, Li S, Yang N. The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients With Coronavirus Disease 2019 (COVID-19) in January and February 2020 in China. Med Sci Monit (2020) 26. doi: 10.12659/MSM.923549

CrossRef Full Text | Google Scholar

236. Silver R, Kriegsfeld LJ. Circadian Rhythms Have Broad Implications for Understanding Brain and Behavior. Eur J Neurosci (2014) 39:1866–80. doi: 10.1111/ejn.12593

PubMed Abstract | CrossRef Full Text | Google Scholar

237. Jagannath A, Taylor L, Wakaf Z, Vasudevan SR, Foster RG. The Genetics of Circadian Rhythms, Sleep and Health. Hum Mol Genet (2017) 26:R128–38. doi: 10.1093/hmg/ddx240

PubMed Abstract | CrossRef Full Text | Google Scholar

238. Gopal SG. A Preliminary Report on Plant Based Immunity Against SARS-CoV-2 (COVID-19) in Pandemic 2020. Res J Biotechnol (2020) 15:174–6.

Google Scholar

239. Du Y, Chen X. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-Ncov Infection. Clin Pharmacol Ther (2020) 108:242–7. doi: 10.1002/cpt.1844

PubMed Abstract | CrossRef Full Text | Google Scholar

240. Asai A, Konno M, Ozaki M, Otsuka C, Vecchione A, Arai T, et al. COVID-19 Drug Discovery Using Intensive Approaches. Int J Mol Sci (2020) 21:2839. doi: 10.3390/ijms21082839

CrossRef Full Text | Google Scholar

241. Sisay M. 3clpro Inhibitors as a Potential Therapeutic Option for COVID-19: Available Evidence and Ongoing Clinical Trials. Pharmacol Res (2020) 156:104779. doi: 10.1016/j.phrs.2020.104779

PubMed Abstract | CrossRef Full Text | Google Scholar

242. Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir Against SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp): A Molecular Docking Study. Life Sci (2020) 253:117592. doi: 10.1016/j.lfs.2020.117592

PubMed Abstract | CrossRef Full Text | Google Scholar

243. Prasad AS. Zinc in Human Health: Effect of Zinc on Immune Cells. Mol Med (2008) 14:353–7. doi: 10.2119/2008-00033

PubMed Abstract | CrossRef Full Text | Google Scholar

244. Wessels I, Maywald M, Rink L. Zinc as a Gatekeeper of Immune Function. Nutrients (2017) 9:1–44. doi: 10.3390/nu9121286

CrossRef Full Text | Google Scholar

245. Zarocostas J. How to Fight an Infodemic. Lancet (2020) 395:676. doi: 10.1016/S0140-6736(20)30461-X

PubMed Abstract | CrossRef Full Text | Google Scholar